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ABSTRACT 
MATHEMATICAL MODELING AND DYNAMICAL ANALYSIS OF THE OPERATION OF 
THE HYPOTHALAMUS – PITUITARY – THYROID (HPT) AXIS IN AUTOIMMUNE 
(HASHIMOTO’S) THYROIDITIS 
 
Balamurugan Pandiyan, B.S., M.S. 
Marquette University, 2011 
 
This thesis is a mathematical modeling study of the operation of the negative feedback 
control through the hypothalamus-pituitary- thyroid (HPT) axis in autoimmune (Hashimoto’s) 
thyroiditis.  Negative feedback control through the HPT axis is a mechanism in which the high 
levels of thyroid hormone; free thyroxine (FT4) in the blood inhibits the secretion of the pituitary 
hormone, thyroid stimulating hormone (TSH) into the blood.  Similarly, the low levels of free 
thyroxine (FT4) sensed by the pituitary gland and then it secretes thyroid stimulating hormone 
(TSH) into the blood.  Autoimmune (Hashimoto’s) thyroiditis is a disease in which the immune 
system turns against the thyroid follicle cells and destroys them slowly for a long period of time.  
This in turn interrupts the operation of the negative feedback control, in fact, the HPT axis.  The 
half-life of thyroid stimulating hormone (TSH) and free thyroxine (FT4) is one hour and seven 
days respectively in the blood.  This implies that thyroid stimulating hormone (TSH) changes in a 
faster time scale than free thyroxine (FT4) both in the healthy and diseased thyroid gland.  Thus, 
the operation of negative feedback control is at least in two different time scales.  The normal 
reference range for TSH and FT4 is used in this thesis are              and           
   respectively.  In thyroid clinics, in general, physicians see three different kinds of patients 
with autoimmune (Hashimoto’s) thyroiditis with or without goiter (enlarged thyroid gland).  
i) Patients with euthyroidism (normal FT4 and TSH levels). 
ii) Patients with subclinical hypothyroidism (normal FT4 but TSH above normal 
levels).  
iii) Patients with overt (clinical) hypothyroidism (low FT4 and TSH above normal 
levels). 
Usually patients with euthyroidism progress to subclinical hypothyroidism and then progress to 
overt hypothyroidism.  This is a sequential event, but in some patients’ cases, it is not true.  
 
To describe the operation of the feedback control in autoimmune (Hashimoto’s) 
thyroiditis, we developed a mathematical model in this thesis involving four clinical (state) 
variables, thyroid stimulating hormone (TSH), free thyroxine (FT4), anti-thyroid antibodies 
(TPOAb and TGAb), and the functional size of the thyroid gland (T).  The first three variables are 
regularly measured in thyroid clinics to determine the function of negative feedback control and 
the status of the thyroid gland in autoimmune thyroiditis.  The last variable is determined through 
relationships between the other three variables and is required for this work to accurately track 
the output of the gland.  The problem of two different time scales is addressed using singularly 
perturbation theory.  Also, the analysis of the mathematical model establishes stability and 
conditions under which the diseased state can be maintained the slow movement of the 
functioning of the negative feedback control toward the diseased state equilibrium. 
  
In this thesis, the purpose of modeling the operation of negative feedback control is to 
describe the natural history of autoimmune (Hashimoto’s) thyroiditis.   This means to describe the 
natural course of euthyroidism, subclinical hypothyroidism or overt hypothyroidism for every 
  
 
 
patient with autoimmune thyroiditis.  Although, we have used four variables in modeling the 
feedback control through the HPT axis, the end product depends on the levels of thyroid 
stimulating hormone (TSH) and free thyroxine (FT4).  In addition, the clinical chart is developed 
based on the levels of thyroid stimulating hormone (TSH) and time.  To validate the model 
description, patient’s dataset are employed in chapter 5.  For this thesis, the dataset is obtained 
from Sicilian adult population, Italy through our clinical collaborator. 
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Appendix A except for   . Here          
            . The 2d reduced system predicts 
that the imaginary individual asymptotically approaches the euthyroid state    
  
  
          in 
approximately 60 days. 
    
Figure 3.5: The phase plane view of Figure 3.4. Note the thyroid functional size     is in 
milliliters and          
            . The reduced 2d system asymptotically approaches 
the euthyroid state    
  
  
          from hashitoxicosis state    
  
  
         . 
   
Figure 3.6: Note the thyroid functional size     is in milliliters. We start the reduced (2d) model 
at the initial state             
  
  
          , having free T4 below lower reference limit of 
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approximately 60 days.  
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         . 
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Figure 3.8: Note the thyroid functional size     is in milliliters. We start the original (4d) model 
at the initial state                      
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the reference range (clinical hypothyroidism), T and Ab normal, plus using the parameter values 
from Table A2 in Appendix A except for   . Here          
            . The 4d 
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approaches the euthyroid state suggestive of the existence of a fast-time-scale for TSH. 
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state   
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            from 
clinical hypothyroidism state     
  
 
   
  
  
           . Note: the reduced 2d system 
approximates the 4d system. Also,    
 
  
        is a small fixed value. 
 
Figure 4.1: Note the thyroid functional size (   is in milliliters. The 4d system, (2.2) – (2.17) 
with the initial condition                 for the parameter values from Table A2, predicts that 
Ab concentration asymptotically approaches zero in approximately 350 days while other 
variables remain at steady state.  This means that the anti-thyroid antibodies did not affect the 
function of the HPT axis. 
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– (2.17) moves from the initial state                                  to euthyroid steady 
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Figure 4.3:  If the initial state                                    is taken on the slow 
manifold, not at euthyroid state, then the 4d system, (2.2) – (2.17) for the parameter values from 
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 , the diseased steady state is not on the surface. Note 
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(representing diseased state). 
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values from Table A2 predicts that Ab concentration asymptotically approaches 6800 in 
approximately 2 years while other variables start at euthyroid state.  Note the thyroid functional 
size (   is in milliliters. 
 
Figure 4.6: For the initial state                 and              
 , the 4d system (2.2) – 
(2.17) for the parameter values from Table A2 predicts that euthyroid state becomes unstable, and 
the trajectory approaches the diseased state. 
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Figure 4.7: If the initial state                                  ) is taken on the level 
curve, not at euthyroid state, then the 4d system, (2.2) – (2.17) for the parameter values from 
Table A2, predicts that the trajectories approaches the diseased state (subclinical hypothyroidism) 
while euthyroid state becomes unstable and shows saddle-type behavior. Note the thyroid 
functional size (   is in milliliters. 
 
Figure 4.8: This figure shows the stability of diseased steady state, the initial state was chosen at 
                       . The reduced system, (2.26) – (2.28) approaches the diseased state 
via euthyroid state. Note the saddle-like behavior near the euthyroid state. Here,            
   
 . Note the thyroid functional size (   is in milliliters. 
 
Figure 4.9: A bifurcation diagram shows a transcritical bifurcation for a range of values  . The 
local bifurcation takes place at            . 
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concentrations     changes as    varies in the model from 0 to 5. Note that the bifurcation 
occurs at      
        .  
 
Figure 4.11: This bifurcation diagram shows how free T4      steady state concentrations 
changes as    varies from 0 to 7.  Observe that the bifurcation occurs at      
  and when    
  
      , we see a patient would have clinical hypothyroidism (see the baseline value of free T4, 
shown as a solid magenta line). 
 
Figure 4.12: This bifurcation diagram shows how     steady state concentrations changes as    
varies from 0 to 7. Also, observe that the bifurcation occurs at      
  and when      
  , 
resulting in clinical hypothyroidism. Thus, the model suggests that at   
  , TSH upper reference 
limit is 2.3 mU/L (approximately). The diseased steady state is still inside the box. 
 
Figure 4.13: This bifurcation diagram shows how the functional size of thyroid gland     
changes as    varies from 0 to 7. Also, observe that the bifurcation occurs at      
 .  
 
Figure 5.1: This figure shows Case 1: euthyroidism  euthyroidism chart. Note: The solid red 
lines illustrate the normal reference range for TSH. The dotted red line chosen for this project as 
an upper TSH reference limit. The green solid line indicates that the 4d system, (2.2) – (2.17) 
approaches the euthyroid (steady) state for ten different    values less than   
 . The initial state of 
the 4d system is                                 .  The parameter values are all from 
Table A2 in Appendix A. 
 
Figure 5.2: This figure shows euthyroidism  subclinical hypothyroidism chart. Note that all 
    solutions go to subclinical diseased steady state. We simulated the 4d system, (2.2) – (2.17) 
with the initial state                 and the parameter values from Table A2 with six different 
   values between    
   (2.3412) and up to   
       .  
 
Figure 5.3: 2d view of euthyroidism  subclinical hypothyroidism chart. We simulated the 4d 
system with the initial state                 and the parameter values from Table A2 but 
different    values, between    
   (2.3412) and up to   
       . The curve in this picture is 
parameterized by six different    values, that is,                              . For every 
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  , we have a diseased steady state (subclinical), that is shown in the picture with a green 
dot. The euthyroid state is shown in the picture with a red dot. 
 
Figure 5.4: log      mU/L versus freeT4      pg/mL view of the previous Figure 5.3. 
 
Figure 5.5: This figure shows the euthyroidism → subclinical → clinical hypothyroidism chart. 
To generate this picture, we picked eleven different    values greater than    
   and then 
simulated the 4d system with initial condition                . The parameter values are all 
from Table A2. 
 
Figure 5.6: 2d view of euthyroidism → subclinical → clinical hypothyroidism chart. We 
simulated the 4d system with the initial state                 and the parameter values from 
Table A2 but different    values. The curve in this picture is parameterized by eleven different    
values greater than   
  .  For every       
   , we have a diseased steady state (clinical 
hypothyroidism), that is shown in the picture with a green dot. The euthyroid state is shown in the 
picture with a red dot. Note an individual progress to clinical hypothyroidism via subclinical 
hypothyroidism. 
 
Figure 5.7: log      mU/L versus freeT4      pg/mL view of the previous Figure 5.6. 
 
Figure 5.8: Clinical staging chart. This chart can be used to determine the natural course of 
subclinical or clinical hypothyroidism or euthyroidism by moving the graph up and down 
according to the patient’s set point (see Validation of Model with Data Section). Note we 
simulated all these curves with different    values in the 4d system using an imaginary 
individual’s table parameter values from Appendix A.  
 
Figure 5.9: Combing Figures 5.7 and 5.4 yields the above parameterized curve. This 
parameterized curve belongs to an imaginary individual that we picked for this project (see 
Appendix A). Since the model (2.2) – (2.17) is patient-specific, each patient has their own curve 
depending on their parameter values and the normal value of the HPT axis.  The euthyroid state is 
shown in the picture with a red dot and diseased steady states are shown with green dots. 
 
Figure 5.10: This figure illustrates patient (#99) natural history of euthyroidism in euthyroidism 
  euthyroidism chart. It seems patient’s     value remains at the euthyroid steady state for 40 
months.  This patient’s euthyroid state for     value is      mU/L   
 
Figure 5.11: This figure illustrates patient (#103) natural course of subclinical hypothyroidism in 
euthyroidism  subclinical hypothyroidism chart. It seems this patient’s TSH value continuously 
increases as time increases. By looking at 3 data points in this chart, we could predict that TSH 
cannot go beyond     mU/L at least for 40 months. Thus, this patient may have chance to become 
subclinical hypothyroidism throughout his life time unless there is some triggering event that 
changes the nature of the immune response and thus   . 
 
Figure 5.12: This figure shows the natural history of patient (#114). This patient reaches clinical 
hypothyroidism via subclinical hypothyroidism. Note this patient’s TSH value increases 
continuously but did not exceed   mU/L in 40 months.  
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Figure 5.13: To generate this 2d picture, log      (mU/L) versus free T4      (pg/mL). We 
simulated the 4d system with patient (#103) parameter values from Table 5.1. Here    was      
and the initial (euthyroid) state was                                           . Note: 
the diseased steady state is located within the normal free T4 reference range. So, the model 
predicts that the patient (#103) may remain in subclinical hypothyroidism unless the immune 
response of this patient changes in the future. 
 
Figure 5.14: To generate this 2d picture, log      (mU/L) versus free T4     )(pg/mL). We 
simulated the 4d system with patient (#114) parameter values from Table 5.1. Here    was      
and the initial (euthyroid) state was                                          . Note: 
the diseased steady state is not located within the normal free T4 reference range. So, the model 
predicts that the patient (#114) will definitely become clinical hypothyroidism patient in the 
future. 
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INTRODUCTION TO A MEDICAL PROBLEM 
 
The thyroid stimulating hormone (TSH), a key hormone, is synthesized and secreted into the 
blood by the pituitary gland. In response to TSH, the thyroid gland secretes thyroxine (T4) into 
the blood, in which 99% of T4 binds to proteins in blood serum such as thyroxine binding 
globulin, albumin and the remaining 1% circulates as free thyroxine (FT4).  This in turn inhibits 
the secretion of TSH in the pituitary gland.  This mechanism is called a negative feedback control 
through the hypothalamus-pituitary-thyroid (HPT) axis.  The existence of the negative feedback 
control is to maintain the adequate levels of free thyroxine (FT4) in the blood, which, in the 
clinical setting, referred to a set point of the HPT axis.  The set point of the HPT axis varies 
greater between individuals than in the same individual sampled repeatedly over time (Andersen 
et al. 2002). 
Autoimmune (Hashimoto’s) thyroiditis is a complex disorder in which the immune 
system attacks the thyroid gland with both proteins and immune cells such as T cells, and 
cytokines for long periods.  More precisely, as one aspect of autoimmune thyroiditis, the immune 
system produces proteins (thyroid peroxidase antibodies, TPOAb and thyroglobulin antibodies, 
TGAb) against the thyroid follicle cell membrane proteins (thyroid peroxidase, TPO and 
thyroglobulin, TG) in the blood.  These proteins (TPOAb and TGAb) induce thyroid follicle cell 
lysis by binding with TPO and TG respectively.  Thus, autoimmune thyroiditis interrupts the 
normal thyroid operation and eventually disrupts feedback control.  Consequently, one develops 
symptoms (like, goiter),signs (like, hyperactivity), and some clinical conditions, like, 
euthyroidism (normal FT4and TSH levels in the blood), subclinical hypothyroidism (normal FT4, 
but TSH above normal levels),overt (clinical) hypothyroidism (underactive thyroid gland- low 
FT4 levels and TSH above normal levels) or hashitoxicosis (transient hyper to hypothyroidism). 
Hashitoxicosis is a life-threatening abnormal clinical condition.  It is one of the rare presentations 
of autoimmune thyroiditis, approximately 5% of all autoimmune thyroiditis patients.  
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From the clinical viewpoint, the presence of anti-thyroid antibodies in blood serum is the 
hallmark of this disease and has been considered as a diagnostic tool of autoimmune thyroiditis in 
healthy and asymptomatic individuals.  Their presence in normal individuals is the risk factor for 
overt hypothyroidism and also believed that, antibodies induce thyroid damage for long periods 
until hypothyroidism is clinically become evident.  As a result, the set point of the HPT axis 
changes for long periods along with damaging thyroid gland.  So, in this thesis, a mathematical 
model will be constructed to track the changes of the set point, in other words, the development 
of overt hypothyroidism.  On the other hand, the absence of anti-thyroid antibodies is strong 
evidence against autoimmune thyroiditis (Shoenfeld et al 2007).  Therefore, individuals with anti-
thyroid antibodies (TPOAb and TGAb) considered being autoimmune (Hashimoto’s) patients in 
the clinical setting. 
In clinical practice, in general, physicians see three different kinds of patients with 
autoimmune (Hashimoto’s) thyroiditis with or without goiter.  
a) Patients with euthyroidism (normal FT4 and TSH levels). 
b) Patients with subclinical hypothyroidism (normal FT4 but TSH above normal levels).  
c) Patients with overt (clinical) hypothyroidism (low FT4 and TSH above normal 
levels). 
Usually patients with euthyroidism progress to subclinical hypothyroidism and then progress to 
overt hypothyroidism.  This is a sequential event in most patients.  But, euthyroidism in some 
patients may persist for many years even lifelong.  This means to say that overt hypothyroidism is 
not an obligated evolution of the autoimmune thyroiditis.  Similarly subclinical hypothyroidism 
in some patients may persist for many years even lifelong.  It means to say that again overt 
hypothyroidism is not an obligated evolution of the autoimmune thyroiditis.  Overt 
hypothyroidism is the end stage of the course of autoimmune thyroiditis where patients need 
thyroid hormone replacement treatment. Levothyroxine (synthetic free thyroxine) is commonly 
used drug as thyroid hormone replacement.  The half-life of thyroid stimulating hormone (TSH) 
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and free thyroxine (FT4) is one hour and seven days respectively in the blood.  This implies that 
TSH changes in a faster time scale than FT4.  Thus, the operation of negative feedback control is 
at least in two different time scales. 
To describe the operation of negative feedback control, that is, the HPT axis, in 
autoimmune thyroiditis, patient-specific mathematical model is required and will be developed in 
this thesis. The model is patient-specific since all autoimmune patients are different.  Modeling is 
done with ordinary differential (rate) equations.  Moreover the problem of two different time 
scales is addressed using singularly perturbation theory.  
Outline of Thesis 
Chapter 1 provides the background materials required for this thesis, such as, physiology of the 
thyroid gland, the HPT axis, autoimmune thyroiditis, and clinical staging.  In autoimmune 
thyroiditis, the clinical evidence suggests that the hypothalamus-pituitary function is intact and 
the thyroid-pituitary function is interrupted.  That is, to say that one part of the operation of 
negative feedback control is normal and the other part is abnormal (see Figure 1.3).  To observe 
this phenomenon in the dataset, we presented several graphs showing the abnormal behavior of 
the HPT axis.  As a final result of the Chapter 1, we established the patient-specific clinical 
staging criterion for patients with autoimmune thyroiditis.  The staging criterion has three general 
cases, namely euthyroidism  euthyroidism, euthyroidism  subclinical hypothyroidism and 
euthyroidism  subclinical  clinical hypothyroidism. 
Chapter 2 provides a four dimensional (4d) non-linear model for patients with 
autoimmune thyroiditis.  To construct this model, we used four clinical variables. Out of four, 
three of them are clinically measurable quantities, thyroid stimulating hormone (TSH), free 
thyroxine (FT4), and anti-thyroid antibodies (TPOAb and TGAb) and the other, the functional 
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size of the thyroid gland (T)
 1
  can be measured through relationships with other three variables. 
The model takes the form of a singularly perturbed initial value problem due to the presence of at 
least two-time scales.  Singular perturbation theory is the main tool for the analysis of a model, 
which is elaborated in this chapter.  The model has eleven parameters - some parameters are 
available from the literature and most are estimated through the equilibrium arguments.  But three 
parameters, namely,       and    turned out to be the governing parameters of the system. 
Through further investigation in Chapter 4, we noticed that    is an important parameter and with 
that we could describe the dynamics of all autoimmune thyroiditis patients.  
Chapter 3 provides the special case of the four dimensional (4d) non-linear model.  That 
is, investigate the 4d model in the aspect of absence of anti-thyroid chronic immune response. 
This resulted in the three dimensional (3d) non-linear model.  We found that 3d model has one 
steady state (set point of the HPT axis) in the positive octant, in fact, inside the trapping 
rectangular box.  In Chapter 3, we referred the steady state to euthyroid state and the arguments 
for constructing rectangular box have elaborated.  Through linear stability analysis, we proved 
that euthyroid state is always stable in the box.  Using singular perturbation arguments, we 
showed that all solutions are attracted to this euthyroid (steady) state.  
Chapter 4 provides the analysis of the dynamics of the 4d model. We constructed a 
rectangular box in 4d space such that the euthyroid (steady) state is trapped inside the box. 
Furthermore, through local stability analysis, we found that    is an important parameter in the 
system, in fact, a bifurcation parameter.  As    changes from zero to the larger range of values, 
we obtained two critical values, one   
  and another   
  .  When      
 , the box contains only 
one steady state which is the euthyroid state and the diseased steady state located in the negative 
orthant.   As    changes in the system, the diseased steady state moves towards the box and when 
     
  , the diseased steady state merges with the euthyroid (steady) state.  When      
 , the 
                                                     
1
The clinical variable T means the functional size of the thyroid gland as opposed to the thyroid size 
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diseased steady state emerges into the rectangular box and becomes stable – we showed that 
through local stability analysis.  But when     reaches the value of   
  , free thyroxine (FT4) 
concentrations goes below the lower reference range         which means clinical 
hypothyroidism.  Therefore, we conclude that, when    is below the critical value   
  , patients 
with autoimmune thyroiditis do not develop the consequences of autoimmune thyroiditis.  When 
   is in between    
   and up to   
  , patients with autoimmune thyroiditis develop subclinical 
hypothyroidism.  When    is greater than   
  , then patients develop subclinical hypothyroidism 
and eventually become clinical hypothyroidism.  
Chapter 5 implements the results of Chapter 4 through clinical staging criterion described 
in Chapter 1.  This in turn results in clinical staging charts.   It is the main result of this thesis. 
The charts are mainly based on TSH because test results of TSH are more reliable in autoimmune 
thyroiditis.  We have given the discussion of how one could use the clinical chart in thyroid 
clinics for all autoimmune patients to describe the natural history and to predict the eventual TSH 
value of particular patient.  In addition to clinical chart, we presented the dynamics in two 
dimensional (TSH versus FT4) phase plane parameterized by   .  Also, we validated the 
mathematical model using patient’s dataset in order to verify the model’s ability to describe the 
natural history of autoimmune thyroiditis. 
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CHAPTER 1 – BACKGROUND MATERIAL 
 
In this chapter, we introduce the background material required for this mathematical modeling 
work.  The background material mainly focuses on the operation of the hypothalamus-pituitary-
thyroid (HPT) axis both under healthy and diseased thyroid gland. The healthy thyroid gland 
preserves the normal operation of the HPT axis while the diseased thyroid gland interrupts the 
normal operation of the HPT axis with the thyroid unable to produce adequate amounts of thyroid 
hormones. The diseased thyroid gland in this work is the consequence of autoimmune 
(Hashimoto’s) thyroiditis. 
1.1    Introduction to Thyroid Physiology  
General Anatomy  
The thyroid is the largest endocrine gland, located in front of the neck just below the larynx or 
above the collar bones (see Figure 1.1). The thyroid gland is butterfly-shaped and consists of two 
wings, called lobes and attached through a middle part called the isthmus. In healthy state, the 
normal adult thyroid gland weighs approximately 10 - 20 g and each lobe of thyroid measures 
about 2.5 - 4 cm in length, 1.5 - 2 cm in width, and 1 - 1.5 cm in thickness, but in diseased state, 
the thyroid weight and size are variable (see Greenspan and Gardner, 2001). 
Function of the Thyroid Gland 
Thyroid stimulating hormone (TSH) is synthesized and secreted into blood from the pituitary 
gland.  In response to TSH, the thyroid gland produces triiodothyronine (T3) and thyroxine (T4) 
and secretes them into the blood.  This is the main function of the thyroid gland. These hormones 
in turn control the metabolic rate in human body. The main thyroid hormone is thyroxine (T4), 
which contains four iodine molecules, whereas triiodothyronine (T3) contains three iodine 
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molecules. In the healthy state, the daily thyroid gland production of T4 is about       . The 
daily production of T3 is about      , of which about 20% is produced by the thyroid gland and 
80% by deiodination of T4 in extra thyroidal tissues (Bunevicius et al. 1999). T4 molecules are 
active longer in the blood than T3, but T3 molecules are more biologically active at the cellular 
level.  Further, approximately 99.98% of T4 in blood binds with plasma proteins (such as 
thyroxine binding globulin (TBG) (60-75%), prealbumin/transthyretin (15-30%), and albumin 
(~10%)(Werner et al. 2005; Robbins and Rall, 1960)) and circulates as bound T4 - the remaining 
0.02% circulates as free (unbound) T4. Similarly, (~ 99.7%) of T3 in blood binds with plasma 
proteins, specifically, TBG.  In the clinical setting, free T4 and TSH are considered to be the most 
reliable measure to determine the status of the thyroid gland (Surks et al. 1990). Their normal 
reference ranges for adult populations for free T4 and TSH are usually between              
and               (Baloch et al. 2003) respectively.  Note that TSH upper reference limit is 
4.0    .  But TSH upper reference limit is a controversial subject, so nowadays, researchers 
suggest to decrease the upper normal range of TSH to 2.5     (Surks et al. 2005) due to the 
clinical observation that patients with TSH between 2.5 to 4     have increased risk of 
progression to hypothyroidism (underactive thyroid gland). 
Thyroid Follicles 
The functional unit in the thyroid gland is the follicle. The follicle consists of thyroid follicle cells 
surrounding colloid. Colloid is the central region in the follicle, and contains the raw materials for 
thyroid hormone production such as thyroglobulin (TG), iodine, thyroid-peroxidase (TPO), and 
other proteins.  The microscopic findings indicate that the shapes and sizes of the follicles are 
irregular (Greenspan and Gardner, 2001), but for modeling purposes, one typically assume 
follicles are roughly spherical in shape (Degon et al. 2004) (see Figure 1.2). But, in our model, 
the shape and size do not matter. Furthermore, blood vessels, lymphatics, parafollicular cells (C-
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cells) and fibrous tissues all surround the follicles and they are completely covered by a network 
of capillaries. 
Thyroid Follicle Cells  
The follicle cells controls the secretion of thyroid hormones in blood based on the level of 
stimulation from the pituitary gland by TSH. The follicle cells become columnar (i.e., elongated 
and rectangular) when stimulated by TSH and are flat when resting. These follicle cells are the 
victims in Hashimoto’s thyroiditis. Charles et al. (1996) noted that the size of the follicles 
depends on the number of follicle cells and the amount of colloid.  If the follicle cells die under 
the diseased state, then it causes the size of the follicles to shrink significantly and results in 
decreased thyroid hormone production from that follicle.  
In the diseased state, the immune cells infiltration a region of the thyroid gland and their 
destructive action makes that region non functional or not active. Thus, the affected region is 
unable to respond to TSH and produce thyroid hormones. Therefore, for our work, we consider 
the active part of the gland (the functional part of the thyroid gland) which is able to respond to 
TSH and produce thyroid hormones.  The size of this active part of the gland we call the 
functional size of the thyroid gland.   
1.2    The Hypothalamus - Pituitary - Thyroid (HPT) Axis 
If the blood levels of free thyroid hormones (T3 and T4) become too low (below a set point), then 
the hypothalamus senses the reduction of free thyroid hormones and secretes thyrotrophic 
releasing hormone (TRH) which stimulates the pituitary gland to make and secrete TSH into the 
blood.  This in turn stimulates thyroid follicle cells to secrete thyroid hormones (T3 and T4) into 
the blood. If the blood levels of free thyroid hormones become too high, and then the 
hypothalamus and/or pituitary gland senses the high levels of free thyroid hormones and reduces 
its secretion of TRH and TSH, which in turn slows down the production of thyroid hormones in 
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thyroid follicle cells. This type of control mechanism is a negative feedback loop the control 
through hypothalamus - pituitary - thyroid axis (see Figure 1.3) (Brown-Grant, 1957; Zoeller et 
al. 2007).  
The principal purpose of the existence of the HPT axis is to maintain the set point of 
TSH, and free thyroid hormones (T3 and T4) within the normal reference range.  The set point 
and normal reference range changes from person to person and it depends on many factors such 
as age, gender, genes, body weight and race (Panicker et al. 2008).  For instance, in children, the 
HPT axis undergoes progressive maturation and modulation until puberty resulting in continuous 
changes in the set point and normal reference range (Nelson et al. 1993).  In general, children 
have higher TSH and lower thyroid hormone levels. On the other hand, higher TSH levels and 
lower thyroid hormones are reported in the elderly people (Surks and Hollowell, 2007), 
suggesting that elderly people have different normal set points for TSH and free thyroid 
hormones (T3 andT4).  In general, in healthy people, variability in TSH, and free thyroid 
hormones (T3 and T4), is greater between individuals than in the same individual sampled 
repeatedly over time, suggesting that different people have different set points for the function of 
HPT axis (Andersen et al. 2002).  
 
 
Figure 1.1: The Thyroid Gland 
 
(see http://nursingninjas.com/nursingschoolblog/2010/05/medical-surgical-rotation/functions-of-
thyroid-hormones/) 
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Figure 1.2: This figure shows a typical follicle from the thyroid gland. It is roughly spherical in 
shape with normal follicle cells, thyroid receptors (TSHR), thyroid peroxidase (TPO) and 
thyroglobulin (TG) in the colloid. 
 
 
Figure 1.3: This figure shows the HPT axis. The sign (-) indicates the existence of a negative 
feedback loop. Note that free thyroid hormones (T3 and T4) are sensed by the pituitary gland and 
the hypothalamus.  
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1.3    Hypothyroidism and its Types 
Hypothyroidism is an underactive thyroid gland, which means the thyroid gland does not produce 
enough thyroid hormones to stay in the reference range (Silverman and William, 1997; Ord, 
1878). The result of hypothyroidism is the slowing down many bodily functions, most 
importantly, metabolism. Hypothyroidism is also known as myxoedema. For the hypothyroidism 
condition, the patients are treated clinically with synthetic thyroxine pills, called Levothyroxine, 
which they must take every day for their entire life (Papapetrou et al. 1972). There are three main 
types of hypothyroidism, namely primary, secondary and tertiary, which result from the 
dysfunction of the thyroid gland, the pituitary, and the hypothalamus respectively.  
Primary Hypothyroidism 
An individual is said to have primary hypothyroidism if the thyroid gland does not produce 
enough of thyroid hormones, but the pituitary and hypothalamus are normal. Primary 
hypothyroidism occurs mainly due to autoimmune (Hashimoto’s) thyroiditis or due to lack of 
dietary iodine. We discuss primary hypothyroidism in detail in next section after the introduction 
of autoimmune (Hashimoto’s) thyroiditis. 
Secondary Hypothyroidism 
An individual is said to have secondary hypothyroidism if the pituitary gland does not produce 
enough of TSH which stimulates the thyroid gland to produce the thyroid hormones, but the 
thyroid and hypothalamus are normal. Secondary hypothyroidism occurs in pituitary tumors, 
radiation and after surgery.  
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Tertiary Hypothyroidism 
An individual is said to have tertiary hypothyroidism if the hypothalamus does not secret 
thyrotropin releasing hormone (TRH) which stimulates the pituitary gland to produce TSH, but 
the thyroid and pituitary are normal. 
Symptoms 
The general symptoms of hypothyroidism are fatigue, drowsiness, forgetfulness, difficulty with 
learning, dry and itchy skin, puffy face, constipation, sore muscles, weight gain and heavy 
menstrual flow. The symptoms are variable among patients; so the only way to know for sure 
whether the patient has hypothyroidism is via blood tests. We will discuss the thyroid function 
test below. 
1.4    Autoimmune (Hashimoto’s) Thyroiditis 
Hashimoto’s thyroiditis or autoimmune thyroiditis, also called chronic lymphocytic thyroiditis, is 
caused by the abnormal immune response to components of the thyroid gland by means of both 
the cellular and humoral response (Chistiakov, 2005). This cellular and humoral immune 
response results in production of T-cells, helper T-cells, B-cells, killer cells, macrophages, and 
cytokines specifically against the thyroid gland (Dayan and Daniels, 1996). These immune cells 
then infiltrate into the thyroid gland and induce damage to thyroid follicles, more precisely 
follicle cells, size and thereby structure, which in turn interferes with the production of thyroid 
hormones, triiodothyronine (T3) and thyroxine (T4).  Autoimmune thyroiditis is characterized as 
a complex disease due to a strong involvement of genetic and environmental contributors to the 
pathogenesis of disease (Burek, 2009). The pathogenesis of autoimmune thyroiditis remains 
unclear to this date and the subject of controversy, although there are many animal models 
published since the mid-1950s demonstrating autoimmune thyroiditis, with different hypothetical 
mechanisms (Nishikawa and Iwasaka, 1999; Rose and Burek, 2000; Kong, 2007). 
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The B-cells responsible for the humoral antibody response produce anti-thyroid 
antibodies, mainly thyroid peroxidase and thyroglobulin antibodies (TPOAb and TGAb), which 
in turn attack the specific thyroid proteins, thyroid peroxidase and thyroglobulin (TPO and TG) in 
the thyroid tissue. Although only one aspect of the immune response, in the clinical setting, these 
anti-thyroid antibodies are considered to be the bio-markers of the level of the immune response 
activity in autoimmune thyroiditis (McLachlan and Rapoport, 1995; Fink and Hintze, 2010). 
Usually, these anti-thyroid antibodies are measured from the patient blood serum in order to 
evaluate the level of intensity of immune response to the thyroid gland. 
Overall, autoimmune thyroiditis induces a slow destruction of the thyroid gland over 
many years, which results in the disruption of function of the HPT axis that controls the thyroid 
physiology. As a result of this progressive destruction of the thyroid, autoimmune thyroiditis 
patients may experience various clinical forms, such as euthyroidism, subclinical or clinical 
hypothyroidism and/or hashitoxicosis (transient form characterized as from hypothyroidism to 
hyperthyroidism or from hyperthyroidism to hypothyroidism – experienced by some at the onset 
of the autoimmune thyroiditis, according to some researchers) (Mazokopakis, 2007) with or 
without diffuse goiter (an enlarged thyroid gland).  
Autoimmune thyroiditis is more common in women than in men and it can occur at any 
age (including, children and adults), but usually shows up in middle-aged women.  In 1912, 
Hashimoto, a Japanese physician (Hashimoto, 1912), described this disease with hypothyroidism 
and goiter (symptom), referred to a classical form. However, some patients do not develop a 
goiter but have hypothyroidism – atrophic form; some patients do develop a goiter but switch to 
atrophic form as the disease progress over time. Little is known about the connection, if any, 
between two forms. Researcher’s suspect that apoptosis (programmed cell death) plays an 
important role at the late stage of the disease that causes atrophy (Kotani et al. 1997). Overall, a 
complicated phenomenon involved in the course of the disease that makes the size of the thyroid 
gland unpredictable.  
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Primary Hypothyroidism  
Primary hypothyroidism results from the destruction of thyroid gland by autoimmune thyroiditis. 
Some people develop this type of hypothyroidism quickly over a few months and some develop it 
slowly over several years – this different behavior depends on the aggression of the immune 
response to the thyroid gland (Tunbridge et al. 1981; Karmisholt et al. 2011).  
Primary hypothyroidism is a graded phenomenon in which the thyroid status changes 
from euthyroid (non-diseased) state to subclinical hypothyroidism and may progress to the overt 
hypothyroidism state. For this transient situation, TSH values are used to monitor the disease 
progression (see Hall and Evered, 1973).  We will now give the clinical definitions of subclinical 
and overt hypothyroidism based on TSH and free T4 values.   
Subclinical (Mild) Hypothyroidism 
Elevated blood levels of TSH                and         , but normal free T4   
          . 
Clinical (Overt) Hypothyroidism 
Elevated blood levels of TSH                 with low free T4            .  
Goiter 
Goiter means an enlarged thyroid gland. It can be treated by a thyroid hormone replacement, 
Levothyroxine (Schmidt et al. 2008). There is no consensus explanation available for the 
appearance of goiter in Hashimoto’s thyroiditis, some hypothesize that either that high blood 
levels of TSH induce a goiter or inflammation of thyroid gland induce a goiter. 
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Hashitoxicosis 
Hashitoxicosis is an autoimmune thyroid condition in which the patient experiences transient 
hyperthyroid episodes. According to some researchers, Hashitoxicosis is most likely to be 
encountered in the early stages of autoimmune (Hashimoto’s) thyroiditis (Mazokopakis, 2007). 
Since the chronic immune response is activated against the thyroid gland at early stages 
of Hashimoto thyroiditis, the thyroid gland releases its stores of thyroid hormones (both T3 and 
T4) and the raw materials for thyroid hormone production into the blood. This sudden burst of 
thyroid hormones, especially T3, is responsible for the transient symptoms of hyperthyroidism. 
1.5    Clinical Tests  
Thyroid function tests are designed to identify the diseased states (hypothyroidism and 
hyperthyroidism) from the healthy state of the thyroid gland (Dunlap, 1990). Here, we will 
discuss a few tests that are necessary for our study.  
TSH Test 
Thyroid stimulating hormone (TSH) is measured through the simple blood test by using a modern 
method of non-isotope immunometric assay (IMA) with highly enhanced sensitivity and 
specificity.  The IMA is capable of achieving a functional sensitivity    0.02 mU/L, which is the 
necessary sensitivity for detecting the full range of TSH values observed between hypothyroidism 
and hyperthyroidism (Baloch et al. 2003).  As stated before, the normal reference range for TSH 
for adult population is                    .  If TSH test results in values that are outside 
the reference range, then thyroid status is not stable. Suppose thyroid status is stable and 
hypothalamic – pituitary function is normal, then serum TSH test is more sensitive and preferred 
test than free T4 test (as discussed below) for detecting subclinical (mild) thyroid hormone excess 
or deficiency. Therefore, the TSH measurement is considered to be the main tool for the detection 
of various degrees of diseased states (such as subclinical hypothyroidism and hyperthyroidism).  
16 
 
 
Free T4 Test 
Thyroxine (T4) in blood is available in two forms. One is bound T4 and the other free T4. There 
is approximately 99.98% bound T4 and 0.02% free T4 in the blood.  There are some physical 
methods exist to separate free T4 from bound T4 that are equilibrium dialysis, ultra filtration and 
gel filtration. Unfortunately, they are technically demanding, inconvenient to use and relatively 
expensive for routine clinical laboratory to use. There are other methods that most clinical 
laboratories employ, that is, indexes and immunoassay, to get an estimate of free T4.  The Index 
method requires two separate measurements - one is a total hormone measurement and the other 
is an assessment of thyroid binding protein concentration using an immunoassay for thyroxine-
binding globulin (TBG) or a T4 uptake test called thyroid hormone binding ratio (THBR) (Baloch 
et al. 2003).   
Anti-thyroid Antibodies (TPOAb and TGAb) Test 
The anti-thyroid antibodies (TPOAb and TGAb) can be measured either by hemagglutination 
assay or radioimmunoassay (RIA).  The summary of these assays are discussed in (Merrill, 1998). 
These methods have been commonly used in thyroid clinics to quantify the anti-thyroid 
antibodies.  
Ultrasound 
Ultrasound can detect thyroiditis because a hypoechoic ultrasound pattern indicates lymphocytic 
infiltration (Rosario et al. 2009; Premawardhana et al. 2000). In addition, ultrasound can detect 
nodules, lumps, and enlargement of the thyroid gland.  In a study of over 3000 prospective 
ultrasounds ordered for a variety of reasons, nearly 15% of subjects displayed evidence of 
hypoechogenicity. 
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1.6    The Operation of the HPT Axis in Hashimoto’s Thyroiditis 
The normal function of the HPT axis depends on the function of the hypothalamus, the pituitary, 
and the thyroid gland.  If something goes wrong with any one of these organs, then the function 
of axis is typically interrupted. In our setting, autoimmune thyroiditis destroys the thyroid gland, 
which affects the operation of the HPT axis (see Figure 1.4).  As a consequence, autoimmune 
thyroiditis patients become euthyroid, subclinical, or clinical hypothyroidism with or without 
goiter. But, most patients successfully regulate free T4 for several years before they become 
hypothyroidism – suggesting that the dynamics of TSH may be interesting in the clinical setting.  
Our primary interest here is to track the development of euthyroidism, subclinical or clinical 
hypothyroidism with or without goiter, using the measurable quantities in blood, TSH, free T4, 
and anti-thyroid antibodies (Ab) along with the other quantity, the functional thyroid size in the 
autoimmune thyroiditis. We also want to demonstrate some known and unknown clinical results 
using a mathematical model.  
 
Figure 1.4:  In autoimmune thyroiditis, there exists a chronic immune response against the thyroid 
gland. Due to immune response, the gland’s hormone production may decrease and this cause the 
interpretion of the operation of the HPT axis. The dotted lines represent the dormant part of the 
HPT axis.  The solid line from hypothalamus to pituitary to thyroid gland is the active part of the 
axis.  
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TSH and Free T4 Relationship 
An understanding of the normal relationship between the blood levels of TSH and free T4 is 
useful when interpreting thyroid function test results. If TSH measurements are to be used to 
evaluate primary thyroid dysfunction (such hypothyroidism/ hyperthyroidism), then it is a 
prerequisite that the function of the hypothalamus – pituitary axis is intact. When hypothalamus – 
pituitary axis function is normal and thyroid status is stable (meaning free T4 normal), then there 
is an inverse log/linear relationship between TSH and free T4 (Spencer et al. 1990). We will show 
this log/linear relationship in our dataset and as a consequence of our model later.  
1.7    Dataset 
We have received a dataset of 119 patients with autoimmune thyroiditis from our clinical 
collaborator, Dr. Salvatore Benvenga, Professor of Medicine, Section of Endocrinology, 
Department of Clinical and Experimental Medicine, University of Messina, Messina, Sicily, Italy.  
This dataset consists of blood serum levels of thyroid stimulating hormone (TSH), free T4 (FT4), 
anti-thyroid antibodies (TPOAb and TGAb) and/ or Levothyroxine (L-T4) taken at different time 
points for every patient.  The unit for time is month. The first measurement of those values for a 
patient is considered time zero (month). Half of our patients received treatment with L-T4 from 
the first visit to thyroid clinic in Sicily (those patients are referred to treated patients from time 
zero).  The anti-thyroid antibodies column has missing values for almost all patients.  For this 
research, we have received Institutional Review Board (IRB) approval from Marquette 
University.   
To be more specific about the dataset, 46 patients with autoimmune thyroiditis received 
no treatment (group1- always untreated, see Figures 1.5 and 1.6) because the levels of free T4 
within laboratory reference range, 51 patients with autoimmune thyroiditis received treatment 
with L-T4 from time zero (group2- treated patients from time zero, see Figures 1.6 and 1.7) and 
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the remaining patients received no treatment initially and then received treatment with L-T4 after 
they developed clinical hypothyroidism (group3, see Figures 1.8 and 1.9). For these groups, the 
duration of follow-up is varied up to some extent. In group1, the average duration of follow-up is 
approximately 24.5 months. In group2, the average duration of follow-up is approximately 32 
months.  In group3, the average duration of follow-up is approximately 28.5 months.  To gain 
insight into patient’s progression toward subclinical hypothyroidism or euthyroidism, we pick 
patient’s data from group1 (see Figure 1.11(M)).  To gain insight into patient’s progression 
toward clinical hypothyroidism, we pick patient’s data from group3 (see Figure 1.11(N)). Also, 
we separated group3 patient’s data into two parts, before treatment and after treatment in order to 
observe the course of the disease (see Figure 1.9). Overall, we observed that patients with 
autoimmune thyroiditis showed high variability in developing subclinical or clinical 
hypothyroidism.  In addition, we observed that the untreated patients mimic the abnormal 
function of the axis and treated patients mimic the normal operation of the axis as we expected. 
The data was collected from different laboratories across Sicily population under the 
approval of government of Italy. These different laboratories had established slightly different 
normal reference ranges and set points of the HPT axis according to the local adult population 
and the measurements are not comparable. So, in order to utilize the entire data set for analysis, it 
is important to scale TSH and FT4 values within the normal reference range adopted for this 
project.  For that, we introduce a simple proportion formula,  
            
   
   
     
          
    
   
   
where         are referred to TSH values in the reference interval                     mU/L 
respectively and           are referred to free T4 values in the reference interval    
              pg/mL respectively. Note         are referred to lower and upper reference 
limit of TSH. Similarly         are referred to lower and upper reference limit of free T4. For an 
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example of scaling, see Table 1.1 and 1.2 below. Let us consider a patient (#103) with normal 
reference range and measured TSH and free T4 values used in the lab. We will now employ the 
above formula to scale TSH and free T4 values into a standard range      –       mU/L and 
       pg/mL. Note: For patient 103,                          . 
Table 1.1 
Patient ID 
Number 
Normal 
Range 
TSH Standard 
Normal 
Range 
TSH 
            
      
        
     
103 0.35 – 5.5 1.4 0.4 – 2.5 0.8282 
103 0.35 – 5.5 1.65 0.4 – 2.5 0.93 
103 0.35 – 5.5 2.26 0.4 – 2.5 1.178 
 
Table 1.2 
Patient ID 
Number 
Normal 
Range 
Free T4 Standard 
Normal Range 
Free T4 
          
    
    
   
103 7 – 17 13.5 7 – 18 14.15 
103 7 – 17 13 7 – 18 13.6 
103 7 – 17 11.8 7 – 18 12.28 
 
2d and 3d-Scatter Plots 
We use two and three dimensional (2d and 3d) scatter plots to explore the autoimmune thyroiditis 
patients dataset.  More precisely, for group1 and group3 (untreated) patients, we use 2d and 3d 
scatter plots to see the abnormality in the function of the HPT axis, nonlinear relationships 
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between clinical variables and inter and intra - variability in developing hypothyroidism.  For 
group2 patients, we use scatter plots to see the normal operation of the HPT axis. 
  
 
 
Figure 1.5: The figures (A and B) show 45 patients with autoimmune thyroiditis from group1. 
Figure A shows all patient’s TSH versus free T4 values taken at different time points. Figure B 
shows patient’s log (TSH)(mU/L) versus free T4(pg/mL). All patients have anti-thyroid 
antibodies but untreated clinically because free T4 levels are normal. 2d plots show how each 
patient is different in the dataset. The solid red lines indicate the reference range of TSH. The 
dotted red line indicates the new upper reference limit of TSH. Note: Temporal component is not 
shown here. 
 
  
 
 
Figure 1.6: 3d plots (C and D) show that all patients from group1 have anti-thyroid peroxidase 
(TPOAb) and/or anti-thyroglobulin (TGAb) in their blood serum. Group1 patients are monitored 
but do not receive L-T4.  Figure C shows patient’s free T4 (pg/mL), TPOAb (U/mL) and TSH 
(mU/L). Figure D shows patient’s free T4 (pg/mL), TGAb(U/mL) and TSH(mU/L). 
 
C D 
A B 
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Figure 1.7: 2d plots (E and F) show treated patients with L-T4 from group2.  Group2 contains 51 
patients (treated from first visit to thyroid clinic – referred to treated patients from time zero). 
Figure E shows patients TSH versus free T4 taken at different time points. Figure F shows 
patient’s log (TSH) versus free T4.  Comparing Figures F and B, we see that group2 patients has 
better inverse log/linear relationship between log (TSH) (mU/L) and FT4(pg/mL) than group1 
patients. 
 
 
 
 
 
Figure 1.8: 3d plots (G and H) show treated patients from time zero from group2. All treated 
patients live with anti-thyroid peroxidase (TPOAb) and/or anti-thyroglobulin (TGAb) in their 
blood serum. Figure G shows patient’s free T4 (pg/mL), TPOAb (U/mL) and TSH(mU/L). Figure 
H shows patient’s free T4(pg/mL), TGAb(U/mL) and TSH(mU/L). 
 
G H 
E F 
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Figure 1.9: 2d plots (I and J) show patients from group3. Group3 contains 22 patients with 
autoimmune thyroiditis. Figure I shows how patient’s progress from euthyroidism to 
hypothyroidism both in terms of TSH and free T4. Figure J shows the data of 22 patients from 
group3 before treatment.  All patients in Figure J progress from euthyroidism to hypothyroidism 
while free T4 within laboratory reference range adopted for this project.  
 
  
 
 
Figure 1.10: 3d plots (K and L) show patients from group3.  It appears that group3 patients 
contain more anti-thyroid peroxidase antibodies rather than anti-thyroglobulin antibodies. Figure 
L shows group3 patients with TPOAb(U/mL) taken at different time points. Figure L shows 
group3 patients with TGAb(U/mL) taken at different time points. 
 
 
I J 
K L 
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Figure 1.11: 2d plots (M and N) show a patient from group1 and group3.  Figure M shows patient 
103 from group1 while Figure N shows patient 114 (before treatment) from group3.  
   
Statistical Test for Nonlinearity 
We will now investigate an inverse log/linear relationship in our dataset through a statistical test 
or model. For that, we first transform TSH values into logarithmic scale, which we call log     
(TSH).  And then, we will construct a linear regression model to evaluate the relationship 
between log (TSH) and free T4. If this model produces a linear relationship, then we conclude 
that there is a non-linear relationship between TSH and free T4.  For more details such as how to 
construct a linear regression model, see (Montgomery et al. 2006). We will use group1 patients 
and group3 patients before treatment dataset for this statistical test.  
We will employ Matlab curve fit toolbox to construct a linear regression model, and 
investigate the statistical quantity R2 which measures the proportion of explained variation in a 
dataset.  In statistics, R2 is a descriptive measure between 0 and 1. If R2 is close to 1, then the 
linear regression model fits the sample dataset better.  If R2 is close to 0, then the linear 
regression model fits the sample dataset poorly. On the other hand, the population measure, the 
Pearson’s correlation   measures the degree of linear relationship between two variables in the 
dataset.  It ranges between -1 and +1. A correlation of +1 means a perfect positive linear 
M N 
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relationship between two variables and -1 means a perfect inverse linear relationship. Note   is 
the estimate of   and the real connection between R2 and   is R2    .  
Figure 1.12 shows the linear regression model for group1 patients and group3 patients 
before treatment.  We found          ,            and this implies R2    .  Also we 
found p-value of t-test < 0.001. Thus, the statistical test confirms a linear relationship between log 
TSH and free T4. Hence, TSH and free T4 have a non-linear relationship.     
 
 
Figure 1.12: The 2d scatter plot showing a linear regression model and the statistical quantities 
(R
2
 and ρ).  It seems R2 = 0.3243, (p < 0.001) and Pearson’s correlation           negative. 
This indicates that there is a linear relationship between log (TSH) (mU/L) and free T4 (FT4) 
(pg/mL). Thus, TSH and free T4 have a non-linear relationship. 
 
1.8    Clinical Staging and Disease Progression 
In autoimmune thyroiditis the immunologic attack is very aggressive and destructive and the 
pathogenesis of the disease is strongly associated with some suspected genes (for instance, non-
MHC class II genes) and environmental factors (for instance, high levels of iodine) (Chistiakov, 
2005).  Every individual is likely to born with one of the predisposition genes in their body which 
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determines whether the individual will develop the clinical states, such as, subclinical or clinical 
hypothyroidism or euthyroidism (none) given an environmental stimulus. We will now discuss 
patient-specific clinical staging for autoimmune thyroiditis.  The staging is important and useful 
to plan treatment. 
Case1:  
Suppose patients with autoimmune thyroiditis (anti-thyroid antibodies are consistently present in 
the blood) do not develop any clinical consequences such as subclinical or clinical 
hypothyroidism, then the staging will be,  
Euthyroidism  Euthyroidism 
Case2: 
Suppose patients with autoimmune thyroiditis develop subclinical hypothyroidism, then the 
staging will be, 
Euthyroidism  Subclinical Hypothyroidism 
Case3: 
Suppose patients with autoimmune thyroiditis develop subclinical hypothyroidism and eventually 
become clinical hypothyroidism, then the staging will be, 
Euthyroidism  Subclinical  Clinical Hypothyroidism 
1.9    Summary 
In this chapter, we introduced the background material required for modeling the operation of the 
HPT axis in autoimmune thyroiditis.  The background material includes thyroid physiology, the 
normal operation of hypothalamus-pituitary-thyroid (HPT) axis, autoimmune (Hashimoto) 
thyroiditis, and the operation of the HPT axis in autoimmune thyroiditis, clinical tests and clinical 
staging.  In addition, we discussed autoimmune thyroiditis patient’s dataset used in this thesis.  
The dataset was obtained from Sicilian adult population, Italy through our clinical collaborator, 
Dr. Benvenga.  We separated the dataset into three groups, namely, group1-always untreated 
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patients, group2-treated patients with L-T4 (from the first visit to thyroid clinic (time zero)), and 
group3-untreated initially but treated after developed hypothyroidism and presented scatter plot 
analysis. We observed that group1 and group3 patients showed the abnormal operation of the 
HPT axis whereas the group2 patients showed the normal operation of the HPT axis. Finally, we 
established patient-specific clinical staging criteria for patients from group1 and group3 in order 
to describe their natural history of autoimmune thyroiditis.
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CHAPTER 2 – A MATHEMATICAL MODEL OF THE HPT AXIS  
 
We devote this chapter mainly to the construction of a mathematical model of the operation of the 
HPT axis in autoimmune (Hashimoto’s) thyroiditis. Recall from the previous Chapter that in 
autoimmune thyroiditis the status of the thyroid gland and the normal function of the HPT axis 
are interrupted. This model is primarily aimed at the middle - age women or adult patients group 
since most of these patients regulate free T4 successfully for several years in spite of an increase 
in TSH and the presence of anti-thyroid antibodies (TPOAb and TGAb) in their blood serum. We 
will first review other models of the thyroid- pituitary system aimed for regulating free thyroxine 
(T4). 
2.1    Literature Review 
One of the remarkable properties of the thyroid gland is to maintain the amount or concentration 
of free T4 within a stable range             .  For that, control mechanisms exist within the 
thyroid gland.  Here, we review some mathematical models from literature describing the 
regulation of thyroid hormones. In 1954, Danziger and Elmergreen (Danziger and Elmergreen, 
1954) developed a mathematical model based on thyroid and pituitary hormones in order to 
explain the mental disorder called periodic relapsing catatonia.   They proposed a set of nonlinear 
differential equations using Langmuir adsorption isotherm, i.e.,  
  
  
    
    
      
        
  
  
  
    
      
                        
where   and   are concentrations of TSH and thyroid hormone respectively at time   and 
                     are positive real constants.  This system of equations describes most of 
normal and malfunctions of the thyroid - pituitary system but the system fails to produce the
29 
 
 
 
 sustained oscillations of the hormone levels, which was believed to be the reason for periodic 
relapsing catatonia.   
In 1956, Danziger and Elmergreen (Danziger and Elmergreen, 1956) proposed another 
mathematical model to account for the sustained oscillations of the thyroid hormone levels, in 
addition to explaining the normal and abnormal operations of thyroid-pituitary system.  They 
assumed the pituitary gland secretes TSH, which activates an enzyme in the thyroid gland.   The 
rate of production of thyroid hormone is considered to be proportional to the concentration of that 
enzyme. Their second mathematical model was as follows, 
  
  
  
                           
                                      
  
  
  
                                                   
  
  
                                                    
where     and   are concentrations of TSH, an enzyme and thyroid hormone at time  .  The 
system is simply referred to thyroid-pituitary regulator.  There are two notable observations from 
this model apart from producing sustain oscillations, firstly they linearized the nonlinear terms 
and added a third differential equation and secondly, by varying specific model parameters, they 
explained the clinical conditions such as hyper - and hypothyroidism.  
In 1959, S. Roston (Roston, 1959) presented a mathematical model of endocrinological 
homeostasis. The model had no enzymatic reaction terms and periodic solutions but had the 
autonomous secretion term for both TSH and thyroid hormones (T3 and T4) from the pituitary 
and the thyroid.  In addition, he assumed i) thyroid hormones bound to serum proteins such as 
(thyroid binding globulin (TBG) and albumin), ii) the physiological volumes Vp , Vx in which 
TSH and thyroid hormones are dissolved are constant over a short period of time, and  iii) the rate 
of secretion of thyroid hormones is proportional to the rate at which TSH passes through the 
thyroid gland.  A mathematical model of S. Roston was as follows, 
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The notable features of this model are all the equations are stated in terms of amounts of TSH 
and thyroid hormones, which distributed homogeneously and instantaneously throughout the 
physiological volumes Vp , Vx and the parameter k1 represents the sensitivity of the pituitary 
gland to thyroid hormones inhibition. Note    is a physiologically standard value of thyroid 
hormones (in concentration units). In other words, the effect of the hypothalamus on the secretion 
of TSH from pituitary can be expressed by changes in the value of a model parameter (k1).   
In 1964, N. Rashevsky (Rashevsky, 1964) published a heterogeneous model of thyroid hormone 
regulator in a discussion of a mathematical theory of the effects of cell structure and diffusion 
processes on the homeostasis and kinetics of the endocrine system. The author kept all the basic 
assumptions of Danziger and Elmergreen (1956) and added the effects of the highly 
heterogeneous assumption of thyroid hormone regulator system.  
In 1965, Norwich and Reiter (Norwich and Reiter, 1965) published a homogenous model 
of thyroid hormone regulation involving a set of linear differential equations expressing the 
relationship between the rates of secretion of thyroxine and of TSH. Using their model, they were 
able to replicate the known behavior of thyroxine and TSH and made certain predictions which 
are amenable to experimental verification or disproval by existing techniques.  
In 1968, Joseph J. Distefano and Edwin B. Stear (DiStefano and Stear, 1968) published a 
model of thyroid hormone regulation including the hypothalamus. In 1976, P. Saratchandran, 
E.R. Carson and J. Reeve (Saratchandran et al. 1976) published an improved mathematical model 
of thyroid hormone regulation by the anterior pituitary gland which accounted for experimental 
data of TSH and thyroid hormones.  In 2008, Mike Degon (Degon et al. 2008) published a 
computational model of the human thyroid gland based on the clinical observation of changes in 
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the dietary iodine and the molecular-pathways in the thyroid gland. This model captures the 
known aspects of thyroid physiology.  
In the next section, we construct a nonlinear model of the operation of the HPT axis in 
autoimmune thyroiditis.  Note that this model is the first mathematical model in the literature to 
study the function of the HPT axis with abnormality in the thyroid gland.  
2.2    Construction of the model 
The model is constructed primarily for patients (especially middle-aged women, or adults) with 
autoimmune thyroiditis.  To construct a model, we first identify the key players in the disease. 
Second, we make assumptions about those key players. Third, we use those assumptions to 
construct the rate equations, which is our model. For patients with autoimmune thyroiditis, the 
key players are thyroid stimulating hormone, free T4, (unbound) anti-thyroid antibodies and the 
functional (active) size of the thyroid gland. Note thyroid stimulating hormone (TSH), free T4 
(FT4), anti-thyroid antibodies (Ab) and the functional size of the thyroid gland (T) varies with 
time in the presence of autoimmune thyroiditis. Also TSH, FT4 and Ab are measurable quantities 
in the clinical setting to diagnose autoimmune thyroiditis but not the functional size of the thyroid 
gland (T). The functional size can be computed using other key players which will be discussed 
later in this Chapter. We now make the following assumptions, 
Assumptions: 
1. Anti-thyroid antibodies attack the thyroid follicle cells whereby the gland stimulates 
more activity of the immune response.  
2. The damaged part of the gland is no longer functional (active) in secreting thyroid 
hormones.   
3. TSH stimulates the functional (active) part of the thyroid gland for growth and hormonal 
secretion. 
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4. TSH disappears from the blood through a non-specific excretion mechanism. 
5. TSH distributes uniformly throughout the functional part of the gland.  
6. The hypothalamus – pituitary function is intact. 
7. The blood concentration of iodine is sufficient for synthesis of hormonal production. 
8. The total TSH receptor concentration in the gland is approximately constant since the 
anti-thyroid antibodies (TPOAb and TGAb) do not attack the TSH receptors (Tamaki, 
1990).  
Let us now define the key players in autoimmune thyroiditis in terms of function of time and 
followed by the rate equations,  
          Concentration of thyroid stimulating hormone        at time   in blood  
          Concentration of free thyroxine         at time   in blood 
        the functional size of thyroid gland (active part of the gland)     at time   
         Concentration of (unbound) anti-thyroid antibodies        at time t in blood 
Rate Equation 2.1 
The rate of change of concentration of     is equated to the secretion rate of     minus the 
excretion rate of    .  That is, 
    
  
                  2 1  
where         and          are the secretion and excretion rate of     respectively. Although, 
it seems appropriate to include the interaction rate of     and the functional size of thyroid gland 
on the right hand side of equation (2.1), however we ignore this term by considering the physical 
nature of the problem that active areas in the thyroid gland getting smaller and smaller as the 
disease progress in the gland.   
We will first model the secretion rate with two terms; one accounts for the maximum 
secretion rate and another for inhibition rate. That is, 
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The term    represents a maximum secretion rate of TSH in the absence of     in the blood 
(Utiger, R.D. 1987). The next term represents the inhibition of maximum secretion rate of    . It 
depends on plasma concentration of    . This term is modeled by using Michaelis – Menten 
kinetics, which made use of a simple mechanism                      
                       
where          , and          represents the concentration of free T4, free T4 unbound 
receptors on the surface of the pituitary gland and/or the hypothalamus (as we remarked before, 
we considered the hypothalamus-pituitary gland as one unit for our work (see Figure 1.3)), and 
free T4-free T4 receptor bound molecules respectively. 
In general, Menten kinetics describes the relationship between the affinity constant (    
and total number of receptors (    on the surface of the pituitary gland and/or the hypothalamus 
(see (Matthews, 1993)).  The affinity constant      can be described as the concentration of     
required for 50% of maximal     inhibition.  Also note that total number of receptors 
corresponds to the maximum secretion rate of    .  
Properties of         
Since  
   
    
  
    
         
                  
Then, 
           
      
      
                 
Remark 
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            is at least twice continuously differentiable 
Therefore the secretion rate decreases/increases as concentration of     increases/decreases. 
We will now model the excretion rate of    .  By assuming that the excretion rate of 
    decreases at a rate proportional to the concentration of     in blood serum (i.e., to say     
excrete through non-specific mechanism - assumption 4). Thus, we write 
               
Remark: 
            
      
     
                 
     
            
Thus, 
    
  
    
      
      
               
Rate Equation 2.2 
We first derive the rate equation for thyroxine (T4) and then later convert    into free T4 in the 
equation using the fact that bound T4 and free T4 are proportional to each other. The rate of 
change of concentration of thyroxine      is equated to the secretion rate of    minus the 
excretion rate of   .  That is, 
   
  
                        
where           and        represents the secretion and excretion rate of    respectively. We 
will first model the secretion rate of    in equation     . To formulate the secretion rate term, we 
consider the active region of the thyroid gland (assumption 3). So, let the thyroid functional size 
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be   and size of a follicle   (constant).  Let the number of follicles be 
 
 
. Let    be the number of 
follicle receptors per follicle (constant, assumption 8). Then total number of follicle receptors 
is 
 
 
  . Let      and          be the free (unbound) receptors and bound receptors 
concentrations. Then          number of unbound receptors and             number 
of bound receptors, where   is the volume of the blood.  Also, observe that, 
                                                     
                
 
  
         
Using stoichiometry,   
         
  
 
  
        
  
            
              are binding, dissociation and production rate constants affiliated with this reaction.  
For this stoichiometry, the rate equations of          and    are, 
          
  
                                          
   
  
                  
Furthermore, using on equilibrium assumption on (2.5), we get  
          
  
     
                 
Substitute (2.4) into (2.7), we get 
          
  
     
      
 
  
             
That is, 
         
 
   
       
 
     
  
     
       
Substitute (2.8) into (2.6), we get 
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where, 
    
     
  
     
    
  
  
Properties of           
   Suppose         or       or    , then             
    Since 
   
  
 
     
      
   or  
   
    
 
     
         
   , then      for all         
We will now model the excretion rate of    in equation     . By assuming that the blood 
serum concentration of    excreted on the basis of first order kinetics, we get this term, 
             
Thus, 
   
  
 
        
        
              
Since physicians measure free T4       to monitor thyroid    secretion in patients with 
autoimmune thyroiditis, we describe (2.9) in terms of    .  By utilizing the fact that bound T4 
      is proportional to free T4     . That is,  
           
                
where   is proportionality constant. 
We obtain, 
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where    
  
   
. 
Rate Equation 2.3 
The rate of change of the functional size (active part) of thyroid gland is equated to the growth 
rate minus the destruction rate of functional thyroid gland. 
  
  
                           
where           and          represent the growth rate and destruction rate of functional 
thyroid gland respectively.   
We will model the growth rate of the functional thyroid gland using two terms; one 
accounting for when     is available in the blood serum and another, when     is not available 
in the blood serum. When     is available in the blood serum, we assume that the growth rate is 
the proportion of concentration of     in blood serum to total number of receptors in the 
functional region. 
That is, 
    
                                                  
        
Furthermore, we will assume that the total number of receptors in the functional region of the 
thyroid gland is directly proportional to the functional size of the gland. That is, 
                                                              
Substitute (2.13) into (2.12), we get, 
   
    
        
Now, we let    
   
   
.  Therefore (2.13) becomes, 
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When TSH is not available in the blood serum (and from assumption (6)), we assume that the 
growth rate of the gland decreases at a physiologically standard constant rate , that is, 
      
Thus, the growth rate of the functional gland is, 
             
   
 
    
where    represents the sensitivity of the thyroid gland to TSH stimulation. 
Properties of           
              does not exist. This implies that there is a singularity at    .  
                .   
We will now model the destruction rate of the functional size of the thyroid gland.  The 
destruction rate of the functional thyroid gland depends on the aggression of the anti-thyroid 
immune response. To model this term, we use anti-thyroid antibodies (TPOAb and TGAb) to 
stand in for immune response (assumption 1) and the functional size (T) for the active part of the 
gland. Therefore, the destruction rate of Ab is assumed to be the interaction rate of anti-thyroid 
antibodies and the functional size of the gland. So, we write 
                  
Properties of          
   if      or     then     . 
The rate equation of the functional size of the thyroid gland is, 
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Rate Equation 2.4 
The rate of change of concentration of unbound anti-thyroid antibodies is equated to the 
production rate of anti-thyroid antibodies due to the destruction of the functional size of thyroid 
gland minus the aging rate of anti-thyroid antibodies respectively.  That is, 
   
  
                         
where         and       represents the production rate of anti-thyroid antibodies due to the 
destruction of the functional size of thyroid gland and the aging rate of anti-thyroid antibodies 
respectively. We will model the production rate of anti-thyroid antibodies using the interaction 
term, that is,                 [Note – this is an important point in defining Hashimoto’s as 
an autoimmune disease, because it reflects our assumption 1 that anti-thyroid immune response 
attacks the thyroid follicle cells whereby the gland stimulates more activity of the immune 
response and that antibody acts as a marker of immune activity]. We will model the aging term 
using the first order kinetics, that is, anti-thyroid antibodies concentration decreases at a rate 
proportional to the levels of anti-thyroid antibodies in the blood (            ).  
Thus, 
   
  
                      
Hence, the four dimensional model (4d) is as follows, 
    
  
    
      
      
                            (2.2) 
    
  
 
        
        
                                   (2.10) 
  
  
    
   
 
                                (2.15) 
   
  
                                                (2.17) 
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with initial conditions associated with the model and the parameters are all positive, that is, 
                                 .  The equations (2.2), (2.10), (2.15) and (2.17) will be 
referred to as (2.2) – (2.17).    
Remark 
The right hand sides of the model       –        are continuous except when     and satisfy a 
local Lipschitz condition in   
 .  
Existence and Uniqueness Theorem 
We will now state the general theorem of existence and uniqueness for the initial value problem 
(Robinson, 2004, page 71).  
Theorem  
Consider the differential equation 
        
where   is a point in    and      is a vector field in   . Assume that both      and 
   
   
    are 
continuous for   in some open set U in   , and that    is a point in U.  
Then there exists a solution      defined for some time interval –       such that  
       .  Moreover, the solution is unique in the sense that if      and      are two such 
solutions with               then they must be equal on the largest interval of time about 
    where both solutions are defined.  Let         be this unique solution with          . 
The solution         depends continuously on the initial condition   . Moreover, let  
T > 0 be a time for which         is defined for      . Let     be any bound on the 
distance between solutions.  Then, there exists a     which measures the distance between 
allowable initial conditions, such that if              then         is defined for       
and  
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for      . In fact, the solution         is differentiable on the initial condition,   . 
Proof: see (Robinson, 2004, page 86 - 89) 
  
Let us now compare the necessary assumptions needed for the existence and uniqueness 
theorem to satisfy in our 4d model. In our model, we have, 
   
   
   
 
  
             and               
 
 
 
 
   
      
      
        
        
       
       
   
   
 
          
              
 
 
 
 
Note      and 
   
   
                are a continuous functions except possibly when    . 
Thus, we require a non-negative open region in    without     in order for the existence and 
uniqueness theorem to work in our 4d model and of course all the initial conditions are non-
negative,    contained within the open set    
 .  
We will now employ the model in an adult population, since they are the ones who 
develop this autoimmune thyroiditis most frequently. For a given adult group, the clinical 
variable normal values, ranges, units and sources are listed in Table 2.1.  Note that the normal 
value of TSH, FT4 and the functional size varies with person to person. So, we arbitrarily picked 
normal values from the reference ranges adopted for this dissertation.  The normal value of anti-
thyroid antibodies is zero. 
 
Table 2.1: Variable Normal Values, Ranges, Units and Sources 
Name Normal 
Value 
Normal Range Source Unit 
    1     –         Literature(Baloch et al. 2003)      
    13       Literature(Baloch et al. 2003)       
  0.015             Literature(Carle et al. 2009)   
   0        Dataset      
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2.3    Singularly Perturbed Structure to 4d Model 
We have observed that thyroid stimulating hormone (TSH) changes on the order of days in the 
blood, free T4 (FT4) changes on the order of weeks in the blood, and the functional size of 
thyroid gland (T) and anti-thyroid antibodies (Ab) changes either on the order of weeks or years, 
possibly depending on the person, the degree of the disease, age, gender, race and so many 
unknown factors.  Thus, there exists at least two different time-scales in the model. We impose 
this assumption of two time-scales present in our 4d model.  We will call TSH a fast state 
variable since it changes on the faster time scale and the rest of the variables (FT4, T, and Ab) are 
slow state variables since they change on the slower (common) time scale.  This in turn gives rise 
to a singularly perturbed structure to our model and also helps us to analyze the model effectively 
by reducing a dimension (see below for the introduction of singularly perturbed initial value 
problem).  The presence of this structure is seen in Chapter1 in the log-linear relationship 
between TSH and free T4. 
Divide (2.2) with   , then we get, 
 
  
    
  
 
   
   
 
      
           
                   (2.18) 
    
  
 
        
        
                                   (2.19) 
  
  
    
   
 
                                (2.20) 
   
  
                                                (2.21) 
Let 
   
 
   
    
Then, we obtain a singularly perturbed structure of our 4d model, 
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Note:  the singularly perturbed model equations numbers are all renamed ((2.18) – (2.21)).  The 
singularly perturbed 4d model is described on the order of intermediate slower time scale, more 
precisely, in terms of weeks (see parameter estimation section in Chapter 4). Also, we could have 
chosen    to define   instead of   . If    was our chosen candidate, the singularly perturbed 
model will be on the order of years (slower time scale). 
Introduction to Singularly Perturbed Initial Value Problem 
Let   denote the “slow” variables and   denote the “fast” variables, then standard autonomous 
singularly perturbed initial value problems are given as, 
 
  
  
                   
       
 
  
  
                           
 
where   a real parameter near a zero and        and       . Because of the presence of 
fast and slow states in the model, singular perturbation problem shows multi-time-scale behavior; 
therefore it is reasonable to analyze the slow and fast state variables on the order of different time 
scales. The original model breaks down into two related sub models, the reduced and boundary 
layer models. We will now show this analysis (see Tihonov, 1952; Hoppensteadt, 1966, and 
1971).  
First, by setting    , we see that the dimensions of state equations reduce from     
to  . Thus, the differential equation (2.22) will change to: 
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after dropping the initial condition        . We call problem (2.23) the reduced model. 
Second, by introducing the stretching transformation   
 
 
  to the problem (2.22) results in, 
  
  
                      
       
  
  
                    
 
Furthermore, by setting     yields 
  
  
   which in turn results in       , a constant 
solution.  We will now let      to obtain the following differential equation, 
 
               
  
  
                                                                                       
 
We call problem (2.25) the boundary layer model.  Thus, in summary, analysis of a 
singularly perturbed initial value problem involves two sub models: the reduced model, and the 
boundary layer model. The former is related to dynamics of the slow variables while the latter 
model reveals the dynamics of the fast variables where      becomes constant. 
For our work, we focus on the reduced model of the singularly perturbed initial value 
problem. Thus, we will now discuss an important theorem of Hoppensteadt (applied to 
autonomous system), where he proved that the solution of singularly perturbed model for small 
    approximates the solution of the reduced model on the time interval        if certain 
conditions on the functions         are satisfied.  
 
Hoppensteadt Theorem (Hoppensteadt, 1966) 
 
Preliminaries: 
Norm of a vector: (required to measure the distances between the solutions of the system) 
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Let             such that            
                and let      and      
represent the restriction of    to  
  and    respectively.  Let us assume that   and   satisfy the 
following conditions. 
1) The reduced model (2.23) has a solution            for all time       . 
2) The functions                             . Here    denotes the matrix with 
components 
   
   
,             and similarly for       and   . 
3) There exists a bounded, twice continuously differentiable function        such that 
            for all       . Furthermore assume      is isolated in the sense that if 
          and            for some         imply             .  
With this assumption, the reduced model can be written in the more convenient form 
  
  
                                                 
4) The function    is continuous at         uniformly in         and          and 
            uniformly asymptotically stable solution. In this assumption, Hoppensteadt 
translated the equilibrium to the origin, but it can be applied to any equilibrium.   
5) The function    is continuous at     uniformly in           and          and its 
derivatives with respect to   and the components of   any   are bounded on   . 
6) Let   be the class of all continuous, strictly increasing, real-valued functions       
    with       ; and let  be the class of all nonnegative, strictly decreasing, 
continuous, real-valued functions     ,      . Let the zero solution of     is 
asymptotically stable. That is, if            is the solution of    , there exist     
and     such that                            for        and     . 
Theorem: 
Let the conditions (1) through (6) be satisfied. Then for sufficiently small           and     
the solution of the original model exists for     and this solution converges to the solution of 
the reduced model as      uniformly on all closed subsets of       . 
 
Remark 
If we remove the uniform condition from (4) and replace        by       from 
Hoppensteadt theorem, we obtain a similar theorem from Tikhonov (1952).  
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Now, from              , we have a reduced model, 
  
   
   
 
      
           
                              
    
  
 
        
        
                                          
  
  
    
   
 
                                       
   
  
                                                       
 
Since the algebraic equation has a unique root,    
    
           
, so we can write our model in 
the more convenient form,  
    
  
 
         
                       
                      (2.26) 
  
  
    
     
            
                               (2.27) 
   
  
                                                                        (2.28) 
The reduced model, (2.26) – (2.28) defines the vector field on the algebraic surface, also called 
slow manifold  
    
           
       .  So, the solution of the reduced model stays on the 
surface  
    
           
       .  We will use the reduced model in Chapter 4 for the stability 
analysis and the numerical simulations. 
2.4    Summary 
This chapter focused on the construction of a nonlinear model of the operation of the HPT axis in 
autoimmune (Hashimoto’s) thyroiditis.  Followed by the construction of the model, we stated and 
compared the existence and uniqueness theorem in non-negative region of four dimensional 
spaces. For this thesis, we chose an adult population and listed their normal values, ranges, units 
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and sources in a tabular format for all model variables, since patients with autoimmune thyroiditis 
are normally from adult populations rather than other populations. The model contains eleven 
parameters and four initial conditions. The model has singularly perturbed structure to it since the 
system has at least two different time scales, which in turn enables one to reduce a dimension of 
the 4d model. 
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CHAPTER 3 – NORMAL AXIS OPERATION 
 
In the previous chapter, we formulated a model which encompasses both normal and abnormal 
operation of the HPT axis.  In this chapter, we will look at the normal operation of the HPT axis 
operation.  For that, we assume there are no anti-thyroid antibodies in the system.  This can be 
done by setting the initial condition (state) of anti-thyroid antibodies to be zero in the singularly 
perturbed model in Chapter 2, solutions starting with         will always have        . 
Thus, the four dimensional (4d) singularly perturbed model becomes a 3d model.  The 3d model 
is, 
 
 
    
  
 
   
   
 
      
           
                      (2.29) 
    
  
 
        
        
                                   (2.30) 
  
  
    
   
 
                                            (2.31) 
3.1    Mathematical Analysis of the Singularly Perturbed (3d) Model 
Remark 
                                           
 
 
 
 
 
   
   
 
      
           
     
        
        
       
   
   
 
    
 
 
 
 
 
    the 3d initial value problem has a unique solution if                        (see 
Chapter 2).  
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Steady states  
For any    , one can solve for steady states by setting the right hand sides of each equation in 
the model,               equal to zero.  If we now solve for steady states which yields, a cubic 
polynomial for      suggesting that the model could predict three meaningful steady states. 
     
    
           
 
   
    
 
 
    
       
  
    
     
     
  
  
   
    
      
    
   
 
    
    
   
In Appendix B, we applied Descartes’ sign rule to the cubic polynomial and noticed that the cubic 
polynomial has one sign change and so therefore, the model has exactly one positive real steady 
state and other two steady states are either negative real or complex depending upon the model 
parameter values.  The existence of positive real steady state is a biologically meaningful state; 
we call this steady state the euthyroid state.  The existence of other two steady states either in the 
negative orthant or complex space is biologically meaningless.  For steady state analysis, we only 
consider the euthyroid state which is as follows (see Appendix B for solving the cubic 
polynomial), 
Let  
  
   
 
 
 
  
 
  
    
  
  
    
    
  
  
   
 
   
   
  
   
   
 
    
   
  
    
   
 
       
  
   
 
  
 
    
 
     
 
Then 
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Note: the euthyroid state depends on the model parameter values suggesting that this state is 
unique for each individual in the adult population.  Also, the euthyroid state is independent of the 
parameter   . 
Let  
     
     
            
      
     
            
      
              
              
  
                   
             
              
    
    
 
        
    
 
 
Then for  
               
             
             
        
  
We have the following theorem. 
Theorem 3.1 (Boundedness)  
The solutions of               with initial conditions in     
  are bounded for all    . 
Proof 
First, let us determine six faces,                                 
                   in   
  such that the faces trap solutions within a rectangular box   
and       where,   the unit outward normal vector to . The 3d rectangular box is 
represented as follows, 
                                      
Second, let      and   be the unit normal vectors in the positive               directions. 
On         ,      and       requires 
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Along the edge          and          for any solution of               on that edge, 
     
   
 
      
    
   
         
   
    
  
         
 
  
 
 
      
    
   
         
                                  
      
    
  
   on edge          and         .  So the sign of the second derivative of 
    is determined by 
    
  
 on that edge. 
    
  
 
         
         
                                           
 
         
         
 
             
         
     
since      
             
             
 and          . Thus, 
     
   
    and     increases on that 
edge.  So the solution would move back into              . 
On         ,     and       requires 
                
    
  
 
        
 
 
 
 
 
     
           
                                
Along the edge          and          for any solution of               on that edge, 
     
   
 
      
    
   
         
 
So the sign depends on 
    
  
. On          and          
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Thus 
     
   
    and     decreases on that edge. So the solution would move back into      
        . 
Therefore, the faces      
     
            
 and      
     
            
, where 
               
Consider now the faces          and         , where              . 
On         ,      and       requires 
                 
    
  
 
        
   
        
        
            
if and only if, 
        
             
                                            
We can now obtain the lower bound for     by choosing      as, 
     
              
                
 
              
             
 
On         ,     and       requires 
               
    
  
 
        
 
        
        
           
if and only if, 
        
             
                                            
We can now obtain the upper bound for     by choosing      as, 
     
              
                
 
              
              
 
Therefore, the faces      
              
            
 and      
              
             
  where 
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Finally let us consider the faces      and      where         .  On     , 
     and       requires 
             
  
  
 
    
     
   
  
                        
Along the edge      and          for any solution of               on that edge, 
  
  
   
 
    
        
     
  
    
     
  
      
  
  
    
        
 
    
    
  
  
  
So the sign is determined by 
    
  
.  On the edge      and         , 
    
  
 
    
      
        
 
    
      
 
    
       
 
This is equal to zero if, in addition         , otherwise 
    
  
  , so   is increasing back into 
the range           except in one case.  To examine the remaining case, if          
     and         , as 
  
  
   and 
   
   
  . We look at  
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So the sign of  
   
   
     
        
        
is determined by 
     
   
.  Consider the second derivative of     at 
              and         . 
     
   
 
      
    
   
         
   
    
  
         
 
  
 
 From the previous case, 
    
  
   and 
    
  
   on          and         .  So 
     
   
 
  at that point this means that   is increasing back into the range        . 
On     ,     and       requires 
           
  
  
 
    
    
   
  
    
     
   
    
                        
On the edge              , 
  
  
   
 
    
        
    
    
  
  
  
From the previous work, 
    
  
   when         , except when         .  Examining 
that case, 
  
  
   
 
    
        
        
    
     
   
  
  
Again from a previous case, we found 
     
   
   and as a result,   is decreasing at the point back into the range        . 
Therefore, the faces    
    
 
 and    
    
 
  where 
        
Thus,  
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Hence the proof 
  
Corollary 
As   in   
  is compact and invariant, there will be a steady state in   (Srzednicki, 1985).  Since 
  lies in the positive region and there is only one steady state in the positive region, it must be in 
 .  
Before we begin the analysis of the 3d model             , we will analyze the 
reduced model by setting     to gain insight into the dynamics on the algebraic surface 
   
   
 
      
           
       . 
3.2    Mathematical Analysis of the Reduced (2d) Model 
Let us consider the reduced model from                
    
  
 
         
                     
                           
  
  
    
     
            
                                  
Notice that the reduced (2d) model describes its dynamics on the algebraic surface (also called 
slow manifold for the reduced model in the literature of singular perturbation theory),  , which is 
as follows, 
               
   
   
 
      
           
         
One could imagine   (2d manifold) embedded in 3d space for   equal to zero.  Thus, we will first 
start with the mathematical (phase plane) analysis of (3.1) – (3.2) in the bounded region   
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contained on the algebraic surface,            and second, we will present the numerical 
simulations of the reduced model to support the analysis.  
Qualitative Behavior of the Trajectories 
Here, we are concerned about the qualitative behavior of the trajectories with initial conditions 
within the bounded region     . We will first start with an array of mathematical definitions 
that are required to construct trajectories within   .   
Consider the autonomous initial value problem, 
  
  
                         
                
  
  
                       
 
where          is continuously differentiable function and         
      
      
  as a vector 
field in   .  
Definition: Forward trajectory  
The forward trajectory through    is the set  
               
   
 
where         is the unique solution with initial condition    (see Chapter2 for general 
construction of  ). 
Definition: Positively Invariant Set 
A set   is said to be a positively invariant set if      then  
         
Definition:             
The            of        is  
               
                                                   . 
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Definition: Stable Manifold 
For an equilibrium state   , the stable manifold of the equilibrium state is given by  
                   
         
    
Before we use all the above definitions; we will do linear stability analysis of the euthyroid state. 
Linear Stability Analysis 
This section is concerned with the stability of an equilibrium (euthyroid) state for the system (3.1) 
– (3.2).   First, note that the euthyroid steady state stays on the slow manifold within the bounded 
region   .  Second, we will test the local and global nature of this state on the slow manifold 
using the reduced system.  Recall again from Chapter 2, the reduced system defines the vector 
field only on the slow manifold. 
Consider the reduced system,  
    
  
 
        
                     
                         
  
  
    
     
            
                                     
 
Lemma 3.1 
The euthyroid state           of             is locally asymptotically stable on the slow 
manifold. 
Proof 
We linearize the model,             near the euthyroid state           . The Jacobian matrix 
at a general point         is, 
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Evaluating the Jacobian at          , we get 
            
 
 
 
 
  
       
   
 
             
   
     
      
 
     
   
    
    
   
 
 
 
 
 
Thus, the linearized system can be written as, 
 
  
  
  
  
             
 
 
  
Observe that, 
          
   
  
    
       
   
 
             
    
and      
     
       
   
   
             
 
     
  
 
        
   
            
   
Thus, the linear system is asymptotically stable.  Hence the euthyroid state           is locally 
asymptotically stable.  Furthermore, since the eigenvalues of matrix            are the roots of 
the characteristic equation 
                   
and the roots are  
 
     
                           
 
    
We have three cases, 
Case1: 
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Suppose                   , then the eigenvalues of   are real.  However, 
                                              
     
                           
 
    
Thus, the euthyroid state is a stable node.   
Case2: 
Suppose                   , then the eigenvalues of   are complex with negative real part, 
therefore the euthyroid state is a stable focus.  
Case3 
Suppose                      then the eigenvalues of   are equal with negative real part 
      
 
 therefore the euthyroid state is a degenerate stable node. 
Remark 
For our system,  
                    
   
  
     
       
   
 
             
 
 
 
         
   
            
 
We call the left hand side as                    for simplicity. For illustration, we use 
parameter values from Table A2 (see Appendix A – parameter estimation) except for   . If 
         
    then,     and then the euthyroid state is a stable node.  If          
    , then    , and then the euthyroid state is a stable focus.  If      or          
  ,    
is approximately zero, therefore the euthyroid state is a degenerated stable node (see Figure 3.1).   
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Figure 3.1: For the values in Table A2, but with    varying, the figure shows how    changes the 
changes the nature of the euthyroid steady state.  Note that the euthyroid state is independent of 
  .  
  
Basin of Attraction for the Euthyroid State  
In this section, we will show that the euthyroid state is an attractor for the set of points on the 
slow manifold.  We show this by employing Dulac’s Criterion and the Poincare - Bendixson 
theorem on the slow manifold.  Recall that the euthyroid state is located within the bounded 
region,     . 
Dulac’s Criterion (Robinson, 2004) 
This method is based on Green’s theorem, which rules out the possibility of closed orbit in the 
planar region. This method works only in 2d space (manifold).  In our case, the planar region is 
the algebraic surface (slow manifold) and the reduced (2d) model             is defined at all 
points on the slow manifold. 
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Theorem: (Dulac’s Criterion) 
Consider the differential equation        where         
      
      
  be a continuously 
differentiable vector field defined on simply connected subset      in the plane. If there exists 
a continuously differentiable, real-valued function        such that 
        
     
  
 
     
  
         has one sign throughout  , then there are no closed orbits 
lying entirely in  . 
Theorem (Poincare-Bendixson) (Robinson, 2004) 
Consider a differential equation       on   . Assume that   is defined on all of   .  Assume that 
a forward trajectory                is bounded. Then       either     contains a steady state 
or      is a periodic orbit. 
Remark 
Let   
  and   be two open sets in   
 . A homeomorphism   from   
  to   is a continuous map 
onto  , which has a continuous inverse   from   to   
 . It follows that   is one to one (i.e., if 
            then      . 
Remark 
We will first use Dulac’s criterion to rule out the possibility of closed orbit in the bounded region 
on the slow manifold and next, by using the Poincare-Bendixson theorem (on the slow manifold), 
we conclude all trajectories of the system       –       converge to the euthyroid state. 
Lemma 3.2 
The euthyroid state           of the reduced system             is an attractor for the set of 
points      contained in the slow manifold   . 
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Proof 
Let         and    . We already have constructed the bounded region      (slow 
manifold) for our reduced (2d) model.  
       
  
    
 
  
  
  
   
           
                      
    
      
            
                         
This implies there are no closed orbits in the bounded region      (slow manifold).  Since 
the bounded region    is compact and positive invariant, therefore, we conclude from the 
Poincare-Bendixson theorem that all trajectories of the system       –       converge to the 
euthyroid steady state.   
  
Theorem 3.2 
For any given initial condition                 in     is on the slow manifold, there exists a 
unique trajectory starting at the initial state which approaches the euthyroid steady 
state           as    . That is, 
   
   
                            
                 
Proof 
We have shown in Theorem 3.1,   is a bounded region, so     is a bounded region on the slow 
manifold.  This means any trajectories of reduced (2d) model       –       starting in      at 
time    will stay there for all future time        and we have also shown that there are no closed 
orbits in    but the euthyroid state by using Dulac’s criterion.  From Lemma 3.1, and 3.2, we 
see that the euthyroid state is locally asymptotically stable and attracts all trajectories starting 
in   .  Thus,                 
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Theorem 3.3 
For any     and initial condition                          , there exists a unique 
trajectory starting at the initial state which approaches to the euthyroid state                
in . 
 That is, 
   
   
                                        
                    
Proof 
We prove this theorem by relating the trajectories of the reduced (2d) model       –       and 
the 3d model               through the Hoppensteadt theorem (see Chapter 2). Hoppensteadt’s 
theorem says that for sufficiently small      and initial condition                         in 
 , the trajectory of the 3d model               exists for      and that trajectory converges 
to the trajectory of the reduced 2d model       –       as      uniformly on all closed subsets 
of     .  Note: in our case,   
 
  
        is a fixed small number and does not converge 
to zero, so the trajectories of the 3d model and 2d model do not converge.  But, the  
         , must be the euthyroid steady state for both the reduced (2d) and 3d model (see Figure 
3.9).  This means that the distance between the trajectories of the reduced (2d) model and the 3d 
model in   must be decreasing in order to share the same           .  In addition,   is 
positively invariant and contains the euthyroid steady state which is locally asymptotically stable 
(see Chapter 4).  Thus, our result follows                  .  
3.3    Numerical Simulations of the Reduced (2d) Model 
We have done the mathematical analysis of the two dimensional reduced system in the bounded 
region on the slow manifold.  In this section, we will present the numerical simulations of the 
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reduced 2d model to confirm our mathematical analysis (see Figures 3.2, 3.3, 3.4, 3.5, 3.6 and 
3.7).  For numerical simulations, we pick an imaginary normal individual, whose normal    , 
free T4 and the functional size are given in Table A1, in other words, euthyroid state of this 
individual is given in Table A1(see Appendix A). For this individual, the parameter values are 
estimated and listed in Table A2 (see Appendix A) however, we use          
   
  
      
  in 
order to confirm our analysis. We start the 2d system with different clinical initial states and 
investigate the dynamics of our imaginary individual.  For all our simulations, we use ode15s 
solver from Matlab suite (see Chapter 4 for specific details).    
 
 
Figure 3.2: The plot of free T4 and the thyroid functional size     as a function of time of a 
simulated individual. Note the thyroid functional size     is in milliliters. We start the reduced 
(2d) model at the initial state             
  
  
          , having free T4 and   within the 
reference range (normal), and using parameter values from the Table A2 in Appendix A except 
for   . Here          
            . The 2d reduced system predicts that the imaginary 
individual probably develops a goiter before the monitored values asymptotically approaches the 
euthyroid state    
  
  
          in approximately 60 days.  
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Figure 3.3:  The phase plane view of the previous time series plot. Note the thyroid functional 
size     is in milliliters. Here          
            . The reduced 2d system 
asymptotically approaches the euthyroid state    
  
  
         . 
 
 
Figure 3.4: Note the thyroid functional size     is in milliliters. We start the reduced (2d) model 
at the initial state              
  
  
          , having free T4 above the upper reference limit 
of free T4 and T normal (hashitoxicosis), and using parameter values from the Table A2 in 
Appendix A except for   . Here          
            . The 2d reduced system predicts 
that the imaginary individual asymptotically approaches the euthyroid state    
  
  
          in 
approximately 60 days.  
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Figure 3.5: The phase plane view of Figure 3.4.  Note the thyroid functional size     is in 
milliliters and          
            . The reduced 2d system asymptotically approaches 
the euthyroid state    
  
  
          from hashitoxicosis state    
  
  
         . 
 
 
Figure 3.6: Note the thyroid functional size     is in milliliters. We start the reduced (2d) model 
at the initial state             
  
  
          , having free T4 below lower reference limit of 
free T4 and T normal (clinical hypothyroidism), and using parameter values from the Table A2 in 
Appendix A except for   . Here          
            .  The 2d reduced system predicts 
that the imaginary individual asymptotically approaches the euthyroid state    
  
  
          in 
approximately 60 days.  
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Figure 3.7: The phase plane view of Figure 3.6. Note the thyroid functional size     is in 
milliliters and          
            . The reduced 2d system asymptotically approaches 
the euthyroid state    
  
  
          from clinical hypothyroidism state   
  
  
         . 
 
3.4    Numerical Simulations of the Singularly Perturbed (3d) Model 
To present numerical simulations of the 3d model, we will use the original 4d model, (2.2) – 
(2.17) by setting the initial condition of anti-thyroid antibodies to be zero (that is,      ). We 
use ode15s from Matlab suite for all our simulations (see Chapter 4 for specific details).  We 
illustrate the mathematical analysis of the 3d model through our simulations. For that, we use our 
imaginary individual’s variable and parameter values from Table A1 and Table A2 in Appendix 
A.  Also, we use          
   
  
      
. 
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Figure 3.8: Note the thyroid functional size    is in milliliters. We start the original (4d) model at 
the initial state                      
  
 
   
  
  
           , having TSH, free T4 outside 
the reference range (clinical hypothyroidism), T and Ab normal, plus using the parameter values 
from Table A2 in Appendix A except for   . Here          
            . The 4d 
system predicts that the imaginary individual asymptotically approaches the euthyroid 
state    
  
 
   
  
  
            in approximately 60 days. Also, observe that TSH quickly 
approaches the euthyroid state suggestive of the existence of a fast-time-scale for TSH. 
 
 
Figure 3.9: 3d phase space view of Figure 3.8. Note the thyroid functional size     is in milliliters 
and          
            .  The reduced 2d system asymptotically approaches the 
euthyroid state    
  
  
          from clinical hypothyroidism state   
  
  
         .  Using the 
algebraic equation,    ,     is computed for the 2d system. The 4d system asymptotically 
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approaches the euthyroid state    
  
 
   
  
  
            from clinical hypothyroidism state 
    
  
 
   
  
  
           .  Note: the reduced 2d system approximates the 4d system. Also,  
  
 
  
        is a small fixed value. 
 
3.5    Summary 
This chapter focused on the dynamics of the normal operation of the HPT axis. For that, we have 
excluded the anti-thyroid antibodies (stand in for anti-thyroid immune response) from the system 
which gave rise to the 3d model. We used the singularly perturbed 3d model in order to reduce a 
dimension of the 3d model and to study the dynamics of the HPT axis on the algebraic surface 
(plane) in an effective manner.  Thus, the reduced 2d model described all its dynamics in the 
plane, in fact, the algebraic surface (also called slow manifold).  In addition, we constructed a 
bounded region in the slow manifold so that if a solution starts within the bounded region at 
time   , it stays there for all future time     .  Finally, we proved that the euthyroid state is 
locally asymptotically stable on the algebraic surface and an attractor for the set of values in the 
bounded region (D).  This is the main result for this Chapter.  We have also presented numerical 
simulations of reduced 2d model             and original 4d model,       –        to confirm 
the mathematical analysis of this Chapter. 
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CHAPTER 4 – ANALYSIS OF DYNAMICS OF 4d MODEL 
 
In this chapter, we present an analysis of the full 4d model which includes investigating the local 
stability of euthyroid state and diseased steady state.  Along with this, we present numerical 
simulations to support stability analysis of the full 4d model. In addition, we present bifurcation 
analysis to determine the qualitative behavior of the system, that is, the structural stability of the 
model as a parameter changes in the system. 
The 4d model is as follows, 
 
    
  
 
   
   
 
      
           
                           
    
  
 
        
        
                                          
  
  
    
   
 
                                       
   
  
                                                       
Remark 
                                            
 
 
 
 
 
 
   
   
 
      
           
     
        
        
       
   
   
 
          
              
 
 
 
 
 
 
    Note that the 4d initial value problem has unique solutions if                  
            (see Chapter 2). 
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4.1    Mathematical Analysis of the Singularly Perturbed (4d) Model 
We begin the analysis of 4d model by examining the steady states of the system. For every    , 
we can find equilibrium states. Setting the left hand side of (2.21) equal to zero yields      
or         . When     , we obtain the euthyroid state (steady state – see Chapter 3 and 
Appendix B), that is,  
      
Let  
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The euthyroid state is located in a hyper plane (      , reasonable initial conditions for the 
system of differential equations are                                            
                          in numerical simulations to investigate the local stability of 
euthyroid state in patients with autoimmune thyroiditis. 
Next, consider a possible equilibrium when     . This requires          and 
substitution of this equilibrium value into the right hand sides of the equation        ,        and 
      , that leads to a steady state in the system, which we call a diseased state,   
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Remark 
If the expression  
      
  
      is true, then the diseased (steady) state is located in the 
negative orthant, that is,      .   
Positively Invariant (Bounded) Region 
We constructed a bounded region in the previous chapter using    ,     and   when the initial 
state of anti-thyroid antibodies is set to zero       . But, now we will establish a bounded 
region in 4d space for the full model when the initial state of anti-thyroid antibodies is not set to 
zero.  Recall the definitions of      and      from the previous chapter – the particular faces 
of the rectangular box . 
Let 
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Then for  
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Theorem 4.1 
If     
    
 
 
  
  
, the solutions of        –        that start in  
  at    will remain in  
  for 
all time     . 
Proof 
We construct eight hyper planes in   
  such that the planes trap solutions within a rectangular box 
   and       where,   the unit outward normal vector to   on seven of the hyper plane 
faces of the box  .  That is, 
                                                 
In autoimmune thyroiditis, we can choose the lower bound for anti-thyroid antibodies     , that 
is,       (the hyper plane).  If a trajectory reaches     , then an argument similar to that in 
Chapter 3 where shows the trajectory stays within the following box, 
                                      
where    
    
 
.  Second, let        , and l be the unit normal vectors in the positive           
and    directions.  In the third case, we established bounds for        , and   in Chapter 3, but 
the lower bound for   is affected in the presence of anti-thyroid antibodies (  ) in the system. 
Thus, we construct a new lower bound for   and upper bound for   , 
On     ,      and       requires 
             
  
  
 
    
      
   
  
               
if and only if 
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By choosing          (minimum value) and         (maximum value), we can obtain 
the lower bound for  , that is, 
    
                             
        
 
But, note that solutions on the edge,                           have 
  
  
   
So, along the edge,                           for any solution of         –        
on that edge, 
  
  
   
 
    
        
      
     
  
    
     
  
      
  
     
   
  
     
  
  
 
    
        
      
 
    
    
  
  
        
   
  
 
So the sign  
   
   
     
        
      
is determined by 
    
  
 and 
   
  
.  We see 
   
  
        
  
  
    and 
    .  On that edge         , and 
    
  
   if         , otherwise 
    
  
   for 
             .  For         , suppose 
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Therefore, when     ,          and       ,      is increasing back into the 
range        .  Thus, 
                             
        
   
    
 
 
Consider now the hyper plane        where         . 
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On       ,     and       requires 
 
             
   
  
 
      
                
if and only if, 
  
   
  
                  
By choosing       
    
 
 (maximum value), we know for sure that the anti-thyroid antibodies 
(Ab) are bounded as long as the following inequality satisfies, 
    
 
 
   
  
 
Thus, we conclude that           . 
Hence the proof 
  
Corollary 
As    in    is compact and invariant, there will be a steady state in    (Srzednicki, 1985). Since 
   lies in the positive region and there is only one steady state (euthyroid state) in the positive 
region, it must be in   . Also, the diseased state is not in the positive region as long as the 
expression  
      
  
      is true.  Thus, the model suggests that the necessary condition for 
the diseased steady state to emerge into the positive region, in fact in the box, is  
      
  
    
 .  In addition, we observed that necessary condition becomes true as    (positive parameter) 
changes in the system (see bifurcation analysis below).   
Theorem 4.2 
When      there is only one steady state (euthyroid state) in the positive octant.  
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Proof 
The proof of this theorem follows from the following definition which relates the euthyroid state 
and diseased steady state.  
Definition 
When 
      
  
    , the second steady state (diseased state) of the system         –         
has     .  So it must coincide with the euthyroid state in the positive quadrant if  
   
   
    
 
   
    
 
Let   
  be the unique value of    where,   
   
              
    
 
In addition, we have observed      
 , 
  
  
  
  
             
    
 
                   
Note: This critical parameter can be uniquely determined for every individual in the adult 
population. 
Remark 
  
  is independent of the parameters           because the euthyroid state is independent of those 
parameters. 
Local Stability of Euthyroid State 
To prove the euthyroid state is locally stable in 4d space. We need Lemma 4.1. 
Lemma 4.1 
Let     be real roots of          .  If     then           (quadratic 
inequality) 
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Proof 
Since                   ,  
If     , both         and         then          . 
  
Theorem 4.3 
The euthyroid state is locally asymptotically stable in         –        if  
     
            
     
 
  
 
                           
 
 
where 
  
   
      
   
           
      
   
      
       
      
             
       
 
Proof 
We will prove this theorem by using the Routh-Hurwitz criteria on our 4d model. We first state 
the Routh-Hurwitz theorem, along with the stability condition for 3d case and then prove our 
claim.  
Routh-Hurwitz Theorem (see Hurwitz, 1895; Routh, 1877; Edelstein-Keshet, 1988) 
Given a characteristic polynomial       
       
          , define   matrices as 
follows: 
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where the       term in the matrix    is 
 
     
 
 
 
                            
        
                                              
  
Then the real parts of the roots are negative if and only if the determinants of all Hurwitz matrices 
are positive: 
                         
May (1973) summarizes these conditions for the cases        . For our problem, we 
will use the case    , which is as follows, 
                   
Let us now consider the Jacobian matrix of full 4d model of (2.18) – (2.21) at euthyroid state  
   
1
2
2 1
3 1 3 1
42
11
5 5 1
6 1 6 12
1 1
7 1 7 1 8
1
0 0
( 4 )
0
( )( )
0
0 0
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a
d
dd
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k k T k TSH
k
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k Ab k T
T T
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 
 
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
 
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 
 
   
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By utilizing   
 
  
 and evaluating       
    
  
            
    
           
, then the Jacobian 
becomes, 
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For this Jacobian matrix, the eigenvalues can be found by solving the characteristic 
equation             .  Note that the euthyroid state is asymptotically stable if and only if all 
the eigenvalues of Jacobian matrix have negative real parts.  For this Jacobian matrix, the 
characteristic equation is, 
                           
   
  
 
 
  
     
 
    
 
      
          
   
   
  
  
     
         
      
We can immediately see that if  
    
  
  
 
   
    
   
  
then one of the eigenvalues              has negative real part and clearly if      
 , there 
is a zero eigenvalue in the direction of anti-thyroid antibodies. 
Let us now consider the equation in the square bracket, 
                
   
  
  
  
     
 
    
 
      
          
   
   
  
  
     
         
     
Rewriting the above, 
      
           
where  
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Substituting   
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Note that           and      since all the parameters are positive and the euthyroid state 
is located in non-negative orthant   
 .  By Routh-Hurwitz condition, the remaining three roots of 
characteristic equation will have negative real parts if and only if  
                      
Clearly               are true, since all parameters are nonnegative. We will now examine 
the condition          . Consider, 
          
     
 
  
 
 
         
     
 
  
       
             
 
  
      
   
        
      
      
       
 
  
      
   
 
      
      
      
 
Divide by        , 
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We want          . By Lemma 4.1, this inequality becomes true if  
     
 
  
 
                           
 
       
where 
  
   
      
   
           
      
   
      
       
      
             
       
 
Hence the proof 
  
Remark 
For the given parameters values in Table A2, we see that the above inequality       is satisfied 
and thus          .  
Observation 
If       
  and inequality       are true, then all four eigenvalues of euthyroid state have 
negative real parts.  If       
  but inequality       is true, then the eigenvalue of euthyroid state 
in anti-thyroid antibodies (Ab) direction becomes zero. Therefore, the euthyroid steady state loses 
its stability to the diseased steady state. In fact, in general, when      
  the euthyroid and 
diseased states merge with each other and exchange stability in the direction of anti-thyroid 
antibodies (see bifurcation analysis section below).  Thus, there is a bifurcation at      
  , but 
we do not know exactly what kind of bifurcation it is at this point. 
If       
   but inequality       holds, then the eigenvalue of euthyroid state in anti-
thyroid antibodies direction will have positive real part and the other eigenvalues of euthyroid 
state have negative real parts and therefore the euthyroid state becomes unstable only in the 
direction of anti-thyroid antibodies. Thus, we conclude that    is a bifurcation parameter for the 
euthyroid steady state. Next, we will study the local stability of the diseased state for        
 . 
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4.2    Mathematical Analysis of the Reduced (3d) Model 
Recall that, for        
  , the necessary condition  
      
  
      for the diseased steady state 
emerge into the box    becomes true. Thus, we have a diseased state in the positive orthant,   
 , 
in fact in   .  We will use Routh – Hurwitz criterion to study the local stability of the diseased 
state.  But, for this, we will use the reduced model from singularly perturbed 4d system – since 
we focus on the operation of the HPT axis in autoimmune thyroiditis and the active part of the 
axis (the hypothalamus-pituitary function is intact) let us reduce a dimension of the 4d model (see 
Chapter 2).  Thus, the reduced (3d) model defines the problem of interest and of course we 
assumed that   is zero, although it is   
 
  
       . Note that the reduced (3d) model is the 
approximation of the singularly perturbed 4d model in a slower time scale. By setting    , we 
obtained the reduced (3d) model (see Chapter 2), which is as follows, 
    
  
 
         
                       
                      (2.26) 
  
  
    
     
            
                              (2.27) 
   
  
                                                                       (2.28) 
Notice that the reduced model describes all its dynamics on the algebraic surface (slow manifold). 
We will call this slow manifold as   , that is, 
                   
   
   
 
      
           
         
One could imagine    (3d manifold) embedded in 4d space for   equal to zero (see Figure 4.3 
and 4.4).  
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Theorem 4.4 
If       
  , the necessary condition  
      
  
      for the diseased state in    becomes true 
and then the diseased state in system        –        is locally asymptotically stable. 
Proof 
We will now apply Routh-Hurwitz criteria and analyze the local stability of the diseased state. As 
a first step, let us compute the Jacobian matrix at the diseased state, which is,  
   
 
 
 
            
                      
   
      
                     
 
       
            
       
            
         
            
 
 
 
Evaluate    with    
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Remark 
If    
   
    
 then          . 
The eigenvalues of the diseased state can be found by solving the characteristic 
equation             , which is, 
      
           
where, 
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                      .  We will now check May’s remaining 
condition          .    
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Notice that  
      
  
       Therefore, the condition           is true for any given a set 
of positive model parameter values and thus the diseased state is always locally asymptotically 
stable once it appears in the positive orthant.  
  
4.3    Numerical Simulations 
The numerical simulations of the four dimensional (4d) system results in trajectories in 4d state 
space (actually 5d with time).  In order to visualize the trajectories of the 4d system, when 
plotting we suppress time and the results of two or more of the four variables.  For numerical 
simulations, we will use the original 4d system      –       , unless there is a need to use the 
singularly perturbed system         –        or the reduced system        –       .   
    
  
    
      
      
                            (2.2) 
    
  
 
        
        
                                   (2.10) 
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                                (2.15) 
   
  
                                                (2.17) 
Since the system       –        contains two different time scales, the Runge - Kutta 
methods such as ode23, ode45 in Matlab suite may not be the best choice for numerical 
approximations.  Recall from Chapter 2 that the two-time scale issue was due to the presence of 
fast and slow variables in the 4d system. This means that a portion of the trajectory varies rapidly 
and the remaining portion of the trajectory varies slowly in 4d state space.  Also, if we use the 
singularly perturbed system         –        for simulations in Matlab, again Runge-Kutta 
methods do not work well since it contains a small parameter     in front of the derivative of 
   .  These systems       –        and         –        are referred to stiff systems in the 
numerical analysis literature. Therefore, we will now introduce the concept of stiff systems, the 
definition of stiffness, and a possible way to avoid stiffness using the ordinary differential 
equation solver in Matlab suite. Next, we will discuss some existing mathematical methods to 
eliminate stiffness in the singularly perturbed system.  
Stiffness 
Stiffness is an important concept in the numerical solution of ordinary differential equations 
which depends on the differential equation, the initial condition, and the numerical method.  
Basically, it affects efficiency, accuracy and graphical output of a computed solution.  Generally 
speaking, whenever there involves a quickly changing dynamics in some components but not the 
others, there is stiffness. 
Definition: Stiff Systems 
Let        be a constant matrix and       .  A linear differential system  
  
  
         
87 
 
 
 
 is said to be stiff if and only if 
1. For all    the real part of each eigenvalue    of       is negative 
2. (Stiffness ratio) 
         
         
   
Remark 
A general nonlinear problem  
  
  
         
is said to exhibit stiffness if the eigenvalues of the Jacobian matrix      
  
  
 behave in a similar 
fashion.  This is because near a particular solution        we may regard  
                 
          
  
                       
Define                .  Then   solves the system  
                 
To tackle stiffness in differential equations using the Matlab suite, we employed the 
standard differential equation solver ode15s.  ODE15s can solve both non-stiff and stiff initial 
value problems, and differential algebraic equations (DAEs). ODE15s is a variable order method 
solver (Shampine and Reichelt, 1997) – it changes the step size when stiff solutions are 
encountered.  Note that the code ode15s is a quasi-constant step size implementation of the 
numerical differentiation formulas in terms of backward differences. The quasi-constant step size 
means that the formulas used are those for a constant step size and the step size is held constant 
during an integration step.  The syntax of this solver for an initial value problem is, 
                                       
Here      is the name of a function that defines the differential equation.  The interval of 
integration is                   and the initial conditions are   .  The code obtains the 
number of equations by measuring the length of the vector   . The vector         is optional 
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and it is built by means of the function        that accepts name-value pairs. The most 
commonly used options are relative (    ) and absolute (    ) tolerances associated with the 
error control. The default value of relative and absolute error tolerances are      and      
respectively.  Throughout our simulations, the default values of relative and absolute error 
tolerances are used.   
Next, we will discuss some mathematical methods to solve stiff systems.  Suppose the 
assumptions of Hoppensteadt theorem are satisfied, particularly assumption (3), that is, the 
algebraic system     has a unique root        with the Jacobian matrix remains strictly 
stable (see Chapter 2), then the reduced problem should be computationally simple since 
complications of stiffness have been eliminated (Dahlquist 1969; Dahlquist and Soderlind, 1982 ; 
Aiken 1985). In our case, the reduced system is as follows, 
    
  
 
         
                       
                      (2.26) 
  
  
    
     
            
                              (2.27) 
   
  
                                                                       (2.28) 
This reduced system (2.26) – (2.28) can be simulated in Matlab using Runge-Kutta 
methods because the solutions of the reduced system are on the same time scale (slow). But we 
found that using ode15s reduces the computational time. Thus, we prefer using ode15s in this 
system to present simulations in            phase space.  
Next, we will discuss another interesting alternative procedure described in (O’Malley, 
R.E, 1988).  Consider the algebraic system     from problem (2.23) from Chapter 2.  
That is,  
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Differentiate     with respect to  . Then, we get, 
  
  
  
   
  
  
   
That is, 
  
  
  
  
  
         
Thus, we have a new set of       differential equations with initial conditions, 
  
  
                                                     
 
  
  
  
  
  
                                       
Note that these equations eliminated the stiffness because the initial condition has been chosen on 
the algebraic surface,              which in turn eliminated the fast dynamics of the problem 
(2.22). Moreover, the trajectories of this system lie completely on the surface (slow manifold). 
Therefore Runge-Kutta methods work well on this system.    
Now, let us rewrite our singularly perturbed system,         –       .  First, consider the 
algebraic system 
                  
  
   
 
      
           
        
Differentiate with respect to  , 
 
    
    
  
     
    
  
   
  
  
    
   
  
   
This yields, 
    
  
  
    
    
 
    
  
 
Thus,  
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                                      (4.3) 
  
  
    
   
 
                                (4.4) 
   
  
                                                (4.5) 
Note that we could use this system, (4.2) – (4.5) instead of         –        for initial condition 
chosen on the algebraic surface,                    . This one requirement actually avoids 
the fast dynamics of the singularly perturbed system and also forces the trajectories to stay on the 
manifold for all    .  But as we remarked in the introduction of the numerical simulations that 
we use the original system, (2.2) – (2.17) wherever it is possible, so let us choose the initial 
condition of TSH from the algebraic surface and use the original system instead of (4.2) – (4.5). 
Also from Hoppensteadt theorem, we know that the trajectories of the original system stay near or 
on the algebraic surface,     for all       . That is, 
    
  
    
      
      
                                   (2.2) 
    
  
 
        
        
                                   (2.10) 
  
  
    
   
 
                                (2.15) 
   
  
                                                (2.17) 
We use this model to present numerical simulations in              and             state 
space.  
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4.3.1    Numerical Simulations of the 4d Model, (2.2) – (2.17) 
All numerical simulations are done using parameters from the Table A2 in Appendix A– we will 
just alter the parameter   .  For the parameter values from Table A2, we obtained   
  
       
 
     
.  We will first look at the case when       
  and investigate the behavior of anti-
thyroid antibody concentrations (Ab) by choosing the initial state exactly at the euthyroid state 
except for anti-thyroid antibodies, that is                                  . Note: in 
euthyroid state,       but we chose       in order to use the 4d model. We present 
simulations both through time series plots and phase-space diagrams in 3d space.  For phase-
space diagrams, we mainly use Hoppensteadt’s theorem that the trajectories of the model stay 
near the slow manifold (surface)     for all time     if we take initial states near or on the 
surface. We use           ,           ) and              phase space diagrams to 
illustrate the results.   
We arbitrarily pick the value of              
  and fix it in the 4d system and then 
simulate the model for approximately 2 years.  In all our Figures below, the red dot represents the 
euthyroid steady state, the green dot represents diseased steady state, the black dot represents the 
initial state of the system, and the yellow surface represents slow manifold for    .  Figure 4.1 
illustrates the 4d system time series plot in which we can see that anti-thyroid antibody 
concentration decreases from the initial state (             ) and approaches zero in 
approximately 350 days while other variables remain at the steady state. Figures 4.2, 4.3 and 4.4 
illustrate the 4d system in                      ) and              phase space.  As we 
see in Figure 4.2, 4.3 and 4.4, the 4d system moves from the initial state to the euthyroid state for 
      
  and the parameter values from Table A2.  Note that in Figure 4.3 and 4.4, the dynamics 
of 4d system is shown near the slow manifold.  In addition, Figure 4.3 and 4.4 shows, the red and 
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black dots on the slow manifold, but not the green dot for       
  and the parameter values from 
Table A2.  
Next, we arbitrarily pick the value of             
  and fix it in the 4d system and 
then simulate the model for approximately 2 years. This will help us to demonstrate the euthyroid 
steady state is no longer attracting the trajectories, but the diseased steady state will emerge into 
the rectangular box for that particular     and attract all trajectories with any initial conditions in 
the box or positive orthant.  Figures 4.5, 4.6, 4.7 and 4.8 illustrate the 4d system moves from the 
initial state to the diseased steady state.  Figure 4.5 and 4.6 shows the red and green dots on the 
slow manifold for       
 .  Note in Figures 4.5 and 4.6, the initial state and euthyroid 
state                , is taken to be the same but not in Figures 4.7 and 4.8.   Again, as we noted 
before, we used parameter values from Table A2 to generate all figures 4.5, 4.6, 4.7 and 4.8.  To 
generate Figure 4.8, we used the reduced (3d) model, (2.26) – (2.28) instead of the 4d system, 
(2.2) – (2.17).   
 
Figure 4.1: Note the thyroid functional size (   is in milliliters. The 4d system, (2.2) – (2.17) with 
the initial condition                 for the parameter values from Table A2, predicts that Ab 
concentration asymptotically approaches zero in approximately 350 days while other variables 
remain at steady state.  This means that the anti-thyroid antibodies did not affect the function of 
the HPT axis.  
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Figure 4.2: For              
  and the parameter values from Table A2, the 4d system, (2.2) 
– (2.17) moves from the initial state                                  to euthyroid steady 
state               . Note the thyroid functional size (   is in milliliters. 
 
 
Figure 4.3:  If the initial state                                    is taken on the slow 
manifold, not at euthyroid state, then the 4d system, (2.2) – (2.17) for the parameter values from 
Table A2, predicts that the trajectory converges to euthyroid state. This suggests the euthyroid 
state is asymptotically stable. Since       
 , the diseased steady state is not on the surface. Note 
the thyroid functional size (   is in milliliters. 
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Figure 4.4: We started the 4d system, (2.2) – (2.17) from                =                 
    and the numerical solutions of the system approaches euthyroid state. Since       
 , the 
diseased steady state is located in the negative octant, so we did not plot the green dot 
(representing diseased state).  
 
We will now investigate the dynamics of the 4d system, (2.2) – (2.17) by arbitrarily 
choosing       
                  
 
     
 .  
 
Figure 4.5: For the initial state                , the 4d system (2.2) – (2.17) for the parameter 
values from Table A2 predicts that Ab concentration asymptotically approaches 6800 in 
approximately 2 years while other variables start at euthyroid state.  Note the thyroid functional 
size (   is in milliliters. 
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Figure 4.6: For the initial state                 and              
 , the 4d system (2.2) – 
(2.17) for the parameter values from Table A2 predicts that euthyroid state becomes unstable, and 
the trajectory approaches the diseased state.  
 
 
 
Figure 4.7: If the initial state                                  ) is taken on the level 
curve, not at euthyroid state, then the 4d system, (2.2) – (2.17) for the parameter values from 
Table A2, predicts that the trajectories approaches the diseased state (subclinical hypothyroidism) 
while euthyroid state becomes unstable and shows saddle-type behavior. Note the thyroid 
functional size (   is in milliliters. 
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4.3.2    Numerical Simulation of the Reduced (3d) Model 
Stability of Diseased Steady State 
We now present the numerical simulations to support that the diseased steady state is stable when 
it is in the positive orthant. For this simulation, we use the reduced system, (2.26) – (2.28) with 
parameter values from Table A2 and visualize the trajectories in            phase space.  
 
Figure 4.8: This figure shows the stability of diseased steady state, the initial state was chosen at 
                       . The reduced system, (2.26) – (2.28) approaches the diseased state 
via euthyroid state. Note the saddle-like behavior near the euthyroid state. Here,           
   
 . Note the thyroid functional size (   is in milliliters. 
 
4.4     Bifurcation Analysis 
General Introduction 
Bifurcation analysis is in general used for analyzing the qualitative behavior of steady states, 
periodic orbits or some other invariant objects, such as a homoclinic or hetroclinic orbit, as 
parameters are varied in the system. The usual definition of bifurcation is that a qualitative 
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change occurs in the topological nature of the solution, when a parameter passes through a critical 
value.  That is, the phase portraits or vector field of the dynamical system before and after the 
bifurcation are not topologically equivalent. There are two important classes of bifurcations in 
literature, namely local and global. Local bifurcations focus on changes that take place near a 
steady state or periodic orbit. This is what we will describe here.  In our 4d system, we analyze 
the qualitative behavior of the steady states as    changes in the system – local bifurcation. There 
are several types of local bifurcations that exist in the literature (Strogatz, 1994, Perko, 1991).  
Qualitative behavior of the system is typically visualized via a bifurcation diagram. A bifurcation 
diagram is a plot which gives a steady state solution as a function of a control parameter.  This 
plot consists of branches that are either solid or dotted lines representing the locations of stable or 
unstable steady states of the system.  Importantly, this diagram shows the long-term system 
behavior as a control parameter is varied.  Next, we will discuss the transcritical bifurcation since 
our 4d system undergoes this bifurcation. 
 
Definition: Transcritical Bifurcation 
A transcritical bifurcation is a local bifurcation in which two steady states of a model involves in 
exchange of stabilities between them. 
 
Example 
Consider the 1d system         . This 1d system has two steady states     and    . 
For    , the steady state     is stable and     is unstable. For    , there is only one 
steady state     which is structurally unstable. For    , there are two steady states, but     
is unstable and     is stable (see Figure 4.9). 
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Figure 4.9: A bifurcation diagram shows a transcritical bifurcation for a range of values  . The 
local bifurcation takes place at            . 
 
4.4.1    Bifurcation Analysis of the 4d Model – Varying the Parameter    
Why    is a control parameter? 
The parameter    in the model is chosen to be a control parameter since the stability analysis of 
the 4d system and the biology of the autoimmune thyroiditis suggested this control parameter. 
From the biological point of view, the parameter    is involved in the production rate of anti-
thyroid antibodies and it is one of the suitable candidates to choose for bifurcation analysis.  Also, 
the biology of the autoimmune thyroiditis suggests that parameters           are potential 
candidates for bifurcation analysis. 
Bifurcation Diagrams 
We will now present the bifurcation diagrams of our 4d system which will help us to see the long 
- term system behavior as    varied. Basically, the bifurcation diagrams depict the complete 
picture of all possible states of the system for large range of values for   . For our 4d system, the 
bifurcation diagrams are drawn by plotting the euthyroid steady state and the diseased steady state 
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for range of values for   .  We observed that when we solve for the steady states in the 
introduction of Chapter 4, the euthyroid state is independent of    and the diseased steady state 
dependent of   .  Furthermore, we observed that the stability nature of the steady states changes 
as    varied.  
Figures 4.10, 4.11, 4.12 and 4.13 shows how the steady states change as the parameter    
is varied.  Stable and unstable steady states are drawn as solid and dotted lines respectively.  In 
particular, Figure 4.10 shows how the anti-thyroid antibodies steady state changes as    varies in 
the model from 0 to 7.  Figure 4.11 shows how free T4 steady state changes as    varies in the 
model from 0 to 7.  Figure 4.12 shows how TSH steady state changes as    varies in the model 
from 0 to 7.  Figure 4.13 shows how the functional size of the thyroid gland steady state changes 
as    varies in the model from 0 to 7.  All these figures illustrates that the euthyroid state is stable 
for the range of values of    from 0 up to   
 .  More precisely, when        
        , the 
euthyroid state is stable.  That is, the real parts of the eigenvalues of euthyroid state are negative 
between 0 and up to   
 .  When      
  , the euthyroid state is unstable.  That is, when     is 
bigger than   
 , the real parts of the eigenvalues of euthyroid state are negative except in the 
direction of anti-thyroid antibodies for the parameter values in Table A2.  Note   
  is the 
bifurcation point where the system undergoes an exchange of stability.  In other words, the 
trajectories of the 4d system before and after   
  are different. A further important clinical 
value,   
  , will be defined in this discussion. All pictures are drawn with parameter values from 
Table A2, except for    is varied. 
 
100 
 
 
 
 
Figure 4.10: This bifurcation diagram illustrates how the anti-thyroid antibodies steady state 
concentrations     changes as    varies in the model from 0 to 7. Note that the bifurcation 
occurs at      
        .  
 
 
Figure 4.11: This bifurcation diagram shows how free T4      steady state concentrations 
changes as    varies from 0 to 7.  Observe that the bifurcation occurs at      
  and when    
  
      , we see a patient would have clinical hypothyroidism (see the baseline value of free T4, 
shown as a solid magenta line). 
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Figure 4.12: This bifurcation diagram shows how     steady state concentrations changes as    
varies from 0 to 7. Also, observe that the bifurcation occurs at      
  and when      
  , 
resulting in clinical hypothyroidism. Thus, the model suggests that at   
  , TSH upper reference 
limit is 2.3 mU/L (approximately). The diseased steady state is still inside the box. 
 
 
 
Figure 4.13: This bifurcation diagram shows how the functional size of thyroid gland     changes 
as    varies from 0 to 7. Also, observe that the bifurcation occurs at      
 .  
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The bifurcation diagrams depicted the qualitative behavior of our 4d model as     varied 
in the system. We found that bifurcation occurred at the numerical value of    
        
 
     
 
for the parameter values from Table A2. In addition, we found that when    increases above the 
value 5.2 results in transition to clinical hypothyroidism. Thus, we called this critical value   
   
and it would be where hypothyroidism takes place. In summary, for       
 , the euthyroid state 
is stable and therefore patients with autoimmune thyroiditis do not develop the consequences of 
autoimmune thyroiditis (such as subclinical and clinical hypothyroidism). For       
 , 
bifurcation occurs, meaning, the disease steady state and euthyroid state merge each other, so the 
patients with autoimmune thyroiditis likely to develop the consequences of the disease in the 
future as     changes further. Finally, for       
  , the euthyroid state becomes unstable and 
patients with kinetic parameter in Table A2 with        
  have autoimmune thyroiditis and 
eventually develop hypothyroidism. More precisely, we found that when    is between   
  and 
   
   results in subclinical hypothyroidism and        
   results in clinical hypothyroidism.  Also, 
we observed that the bifurcation diagrams predicted the proper upper limit for TSH (2.3) mU/L, 
which indicates the validation of the 4d system for Table A2 values.  
4.5    Summary  
This chapter mainly focused on the stability and bifurcation analysis of 4d system. We derived 
conditions for the euthyroid steady state to be stable and unstable in 4d space in the presence of 
anti-thyroid chronic immune response. We found that    is a bifurcation parameter. The 4d 
system undergoes a transcritical bifurcation as    changes in the system which results in diseased 
steady state to emerge in a rectangular box.  We have proved that this disease steady state is 
locally asymptotically stable.  Next, in order to find out the nature of the diseased steady state, 
whether subclinical or clinical hypothyroidism, we preformed bifurcation analysis in the 4d 
system.  This analysis showed that if       
 , the patients with autoimmune thyroiditis do not 
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develop any consequences of the disease and if    
         
   the patients with autoimmune 
thyroiditis develop subclinical hypothyroidism.  If        
  , the patients with autoimmune 
thyroiditis and eventually develop clinical hypothyroidism.  This is our main result for this 
chapter.  In addition, through bifurcation analysis, we found that the upper TSH reference limit 
is     mU/L by using the parameter values from Table A2.  Note that for numerical simulations 
and bifurcation analysis, we used the parameter values from Table A2.  This means to say that 
each patient’s    
  and   
   is different because patient’s euthyroid steady state (set point) is 
different. 
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CHAPTER 5 – CLINICAL STAGING AND DISEASE PROGRESSION 
 
The goal of this project is to provide a patient-specific description of the natural history of 
autoimmune thyroiditis through a mathematical model. What does this mean? It means to 
determine the natural course of subclinical or clinical hypothyroidism through a model for each 
patient. By using a staging criterion for autoimmune disease patients, we can describe this natural 
clinical course.  We will first start this chapter with the summary of results of analyzing the 
operation of the HPT axis from the previous chapters.  
 In Chapter 1, we have observed that the hypothalamus-pituitary function is intact and the 
thyroid-pituitary function is interrupted in diseased patients. We have used the dataset to 
show the motivation of this mathematical modeling project and, in addition, established a 
patient-specific clinical staging criterion for diseased patients. The staging criterion has 
three cases, namely euthyroidism  euthyroidism, euthyroidism  subclinical 
hypothyroidism and euthyroidism  subclinical  clinical hypothyroidism. 
 In Chapter 2, we have constructed a higher dimensional non-linear model for patients 
with autoimmune thyroiditis. The model takes the form of a singularly perturbed initial 
value problem. This is the main tool for the analysis of a model, which is elaborated in 
this chapter.   
  In Chapter 3, we looked at the special case of the model, that is, the absence of anti-
thyroid chronic immune response in a singularly perturbed initial value problem– it 
mimics the normal axis operation. 
 In Chapter 4, we have presented the stability analysis of a singularly perturbed initial 
value problem. We found that    is a bifurcation parameter. As this parameter changes up 
to the critical value   
  , the individuals with autoimmune thyroiditis do not develop the 
consequences of autoimmune thyroiditis, but above the critical value,   
  , the individuals 
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with autoimmune thyroiditis develop subclinical hypothyroidism. Furthermore, we found 
another critical value   
  , where patients eventually develop clinical hypothyroidism.  
We will now use    values to relate clinical staging defined in Chapter 1 and along with 
that, the numerical simulations are presented to support our staging both via time series plots and 
phase space. In time series plots, we will show     values since the hypothalamus-pituitary 
function are normal and therefore,     values are more reliable in autoimmune thyroiditis 
patients. But, in phase-space both     and free T4       will be presented unless there is a need 
for other clinical variables    and      The main reason for presenting only     and free 
T4      in phase-space is because these two hormones are measured regularly in the clinical 
setting and for treating patients. Thus, after presenting numerical simulations the dataset will be 
used subsequently for validating the model prediction. 
Case 1 
Suppose       
  , then patients with autoimmune thyroiditis do not develop any clinical 
consequences (subclinical or clinical hypothyroidism) and thus a staging will be, 
Euthyroidism  Euthyroidism 
Case 2 
Suppose   
        
    then patients with autoimmune thyroiditis develop the subclinical 
hypothyroidism. Thus, a staging will be, 
Euthyroidism  Subclinical Hypothyroidism 
Case 3 
Suppose       
    then patients with autoimmune thyroiditis develop subclinical hypothyroidism 
and eventually become clinical hypothyroidism. Thus, a staging will be, 
Euthyroidism  Subclinical  Clinical Hypothyroidism 
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5.1    Numerical Simulations for Clinical Charts 
For numerical simulations, we use a full model with Ode15s solver in Matlab 7.1.1.0 suite.  
Case 1: Let us pick arbitrarily ten different    values, less than   
  and the initial state of the 
system is at the euthyroid state except for anti-thyroid antibodies, that is,                   
               .  
 
Figure 5.1: This figure shows Case 1: euthyroidism  euthyroidism chart. Note: The solid red 
lines illustrate the normal reference range for TSH. The dotted red line chosen for this project as 
an upper TSH reference limit. The green solid line indicates that the 4d system, (2.2) – (2.17) 
approaches the euthyroid (steady) state for ten different    values less than   
 . The initial state of 
the 4d system is                                 .  The parameter values are all from 
Table A2 in Appendix A.   
 
Case 2: Let us arbitrarily pick six different    values                               between   
   
(2.3412) and up to   
        and the initial state of the system is at the euthyroid state except for 
anti-thyroid antibodies, that is,                                . We use parameter values 
from Table A2 to generate the euthyroidism  subclinical hypothyroidism chart (see Figure 5.2). 
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Figure 5.2: This figure shows euthyroidism  subclinical hypothyroidism chart. Note that all 
    solutions go to subclinical diseased steady state. We simulated the 4d system, (2.2) – (2.17) 
with the initial state                 and the parameter values from Table A2 with six different 
   values between    
   =2.3412 and up to   
      .  
   
 
Figure 5.3: 2d view of euthyroidism  subclinical hypothyroidism chart. We simulated the 4d 
system with the initial state                 and the parameter values from Table A2 but 
different    values, between    
   =2.3412 and up to   
      . The curve in this picture is 
parameterized by six different    values, that is,                             . For every 
      
  , we have a diseased steady state (subclinical), that is shown in the picture with a green 
dot. The euthyroid state is shown in the picture with a red dot. 
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Figure 5.4: log      versus freeT4      view of the previous Figure 5.3. 
 
Case3: Let us pick arbitrarily eleven different     (5.5, 6.8, 8.14, 9.4, 10.7, 12.1, 13.4, 14.7, 16, 
17.3, 18.7) values greater than   
      , and the initial state of the system is at the euthyroid 
state except for anti-thyroid antibodies, that is,                                 .  We use 
parameter values from Table A2 to generate the euthyroidism  subclinical  clinical 
hypothyroidism chart (see Figure 5.4). 
 
Figure 5.5: This figure shows the euthyroidism → subclinical → clinical hypothyroidism chart. 
To generate this picture, we picked eleven different    values greater than    
   and then 
simulated the 4d system with initial condition                . The parameter values are all 
from Table A2. 
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Figure 5.6: 2d view of euthyroidism → subclinical → clinical hypothyroidism chart. We 
simulated the 4d system with the initial state                 and the parameter values from 
Table A2 but different    values. The curve in this picture is parameterized by eleven different    
values greater than   
  .  For every       
   , we have a diseased steady state (clinical 
hypothyroidism), that is shown in the picture with a green dot. The euthyroid state is shown in the 
picture with a red dot. Note an individual progress to clinical hypothyroidism via subclinical 
hypothyroidism. 
 
 
Figure 5.7: log      versus freeT4      view of the previous Figure 5.6. 
 
We will now combine euthyroidism → subclinical hypothyroidism and euthyroidism → 
subclinical → clinical hypothyroidism charts and present it as one complete chart. 
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Figure 5.8: Clinical staging chart. This chart can be used to determine the natural course of 
subclinical or clinical hypothyroidism or euthyroidism by moving the graph up and down 
according to the patient’s set point (see Validation of Model with Data Section). Note we 
simulated all these curves with different    values in the 4d system using an imaginary 
individual’s table parameter values from Appendix A.  
 
 
Figure 5.9: Combing Figures 5.7 and 5.4 yields the above parameterized curve. This 
parameterized curve belongs to an imaginary individual that we picked for this project (see 
Appendix A). Since the model (2.2) – (2.17) is patient-specific, each patient has their own curve 
depending on their parameter values and the normal value of the HPT axis.  The euthyroid state is 
shown in the picture with a red dot and diseased steady states are shown with green dots. 
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5.2    Discussion of using Patient’s Dataset 
We will first discuss how one could determine the euthyroid steady state from patient’s dataset 
and next, we will depict how many data points of a patient are required to describe the natural 
clinical course of subclinical, clinical hypothyroidism or euthyroidism. Euthyroid steady state 
means the set point (normal value) of the HPT axis in the clinical setting. The clinical definition 
of the set point is a value of TSH and free T4, within the normal reference range of TSH       
             and free T4             .  Normally, the set point varies between 
individuals due to inter and intra variations in the adult population. Suppose if a patient has 
several values for TSH and free T4 (of course at different time points) within the reference range, 
then our best guess for the euthyroid steady state (set point) is the first data point.  
Needless to say, with one data point (say just euthyroid state or set point) of TSH and free 
T4, it will be very hard to describe the patient’s clinical course of subclinical, clinical 
hypothyroidism or euthyroidism. With two data points of TSH and free T4 at different time 
points, one could describe the clinical course using the chart but may not be the better description. 
With three or more data points of TSH and free T4 at different time points, one could provide a 
better description of patient’s clinical course of subclinical, clinical hypothyroidism or 
euthyroidism using the chart.  Therefore, we need at least three or more data points in order to use 
the chart effectively and make some conclusion about the eventual value (diseased steady state) 
of TSH. 
In section 5.1, we generated clinical charts using an imaginary individual’s table values 
from Appendix A. Recall that our imaginary individual’s euthyroid steady state (set point) is 
                .  Although the euthyroid steady state varies between individuals, the 
dynamics of the clinical variables (TSH and free T4) do not change (see Figure 5.11 and 5.12) so 
instead of calculating the parameter values for every patient and simulate their own dynamics. 
We will just move the clinical chart up and down according to the euthyroid steady state (first 
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data point) of the patient (see Figure 5.11) in order to describe the patient’s natural history of 
autoimmune thyroiditis. 
5.3    Validation of Model with Dataset 
Let us consider a patient (#99) from group1 (always untreated patients dataset) for model 
validation. We will use euthyroidism  euthyroidism chart for this patient. Patient’s initial 
(euthyroid) state is taken to be the first data point of TSH. That is,         .  
 
Figure 5.10: This figure illustrates patient (#99) natural history of euthyroidism in euthyroidism 
  euthyroidism chart. It seems patient’s     value remains at the euthyroid steady state for 40 
months.  This patient’s euthyroid state for     value is      mU/L   
 
Let us now consider a patient (#103) from group1 (always untreated patients) and a patient (#114) 
from group3 (untreated initially and then received treatment after developed hypothyroidism, see 
Chapter1) for model validation. For patient (#103), we will use euthyroidism  subclinical 
hypothyroidism chart.  For patient (#114), we will use the complete clinical staging chart from 
Figure 5.8.  In practice, one could move the clinical staging chart up and down according to the 
initial (euthyroid) state of the patient, but for numerical simulation one cannot. So, we will choose 
the initial state of both patient (#103 and #114) and compute all the parameters as outlined in 
Appendix A and simulate the 4d system. The initial state for patient (#103 and #114) is taken to 
be the first data point of TSH, free T4, anti-thyroid antibodies and the functional size of the 
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thyroid gland.  The functional size is chosen in the manner of Appendix A.  So, the initial state 
for patient (#103) is                                         .  Similarly the initial state 
for patient (#114) is                                         .  The model parameter 
values are listed in the following Table 5.1 to generate the charts (see Figures 5.11, 5.12).  Also 
Figure 5.13 and 5.14 illustrate the 2d curve of the patient (#103 and #114) respectively.  From 
Figures 5.11, and 5.13, we could see that the patient (#103) developed subclinical 
hypothyroidism.  From Figures 5.12 and 5.14, we could see that the patient (#114) eventually 
developed clinical hypothyroidism via subclinical hypothyroidism.   
Table 5.1: Parameter Estimated Values, and Units 
Name Patient (#103) 
Estimated Value 
Patient (#114) 
Estimated Value 
Unit 
   5000 5000   
     
 
   16.6355 16.6355  
   
 
   100 100 
  
        
 
   0.099021 0.099021  
   
 
   1 1  
 
      
 
   1 1   
     
 
   0.035 0.035  
   
 
   0.039 0.074034 
  
  
 
   0.0083 0.0147   
 
 
  58.516 96.505   
  
 
 
Note: the parameters                 are the same numbers as in Appendix A.  To generate the 
chart, Figure 5.11, we used six different    values                               between   
   
(2.485) and   
       .  Note    
  and   
   values changed a bit for patient (#103).  Similarly to 
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generate the complete clinical chart in Figure 5.12, we used fourteen different    values,  
                                                                . For patient (#114),    
  
       and   
       . 
  
Figure 5.11: This figure illustrates patient (#103) natural course of subclinical hypothyroidism in 
euthyroidism  subclinical hypothyroidism chart. It seems this patient’s TSH value continuously 
increases as time increases. By looking at 3 data points in this chart, we could predict that TSH 
cannot go beyond     mU/L at least for 40 months. Thus, this patient may have chance to become 
subclinical hypothyroidism throughout his life time unless there is some triggering event that 
changes the nature of the immune response and thus   . 
 
  
Figure 5.12: This figure shows the natural history of patient (#114). This patient reaches clinical 
hypothyroidism via subclinical hypothyroidism. Note this patient’s TSH value increases 
continuously but did not exceed   mU/L in 40 months.  
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Figure 5.13: To generate this 2d picture, log      (mU/L) versus free T4      (pg/mL), we 
simulated the 4d system with patient (#103) parameter values from Table 5.1. Here    was      
and the initial (euthyroid) state was                                           . Note: 
the diseased steady state is located within the normal free T4 reference range.  So, the model 
predicts that the patient (#103) may remain in subclinical hypothyroidism unless the immune 
response of this patient changes in the future. 
 
 
 
Figure 5.14: To generate this 2d picture, log      (mU/L) versus free T4     )(pg/mL), we 
simulated the 4d system with patient (#114) parameter values from Table 5.1.  Here    was      
and the initial (euthyroid) state was                                          .  Note: 
the diseased steady state is not located within the normal free T4 reference range. So, the model 
predicts that the patient (#114) will definitely become a clinical hypothyroidism patient in the 
future. 
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5.4    Results and Summary 
In this chapter, we related a patient-specific clinical staging with a model. We mainly presented 
charts, namely, euthyroidism  subclinical hypothyroidism chart and euthyroidism  subclinical 
  clinical hypothyroidism chart and a combined chart involving only TSH and time (months), 
because in autoimmune thyroiditis, the hypothalamus-pituitary function is intact.  These charts 
can be used in thyroid clinics to predict the natural clinical course of subclinical or clinical 
hypothyroidism in autoimmune patients.  For that, we need at least three data points of TSH with 
respect to three different time points.  This means, in simple language, that a doctor, using the 
TSH test, may be able to distinguish between those who will not develop thyroid problems and 
those who may become thyroid patients.  Furthermore, the doctors will be able to treat sooner 
those destined for autoimmune thyroiditis related diseases. In addition, we presented the 
parameterized curve involving free T4 and TSH phase space. 
From the mathematical viewpoint, the goal of this project is to identify a curve based on 
TSH that an autoimmune patient follows as time changes. This curve predicts whether a patient 
progress to subclinical or clinical hypothyroidism diseased state.  If this curve is known, then 
patient diseased dynamics is known to physicians and thereby plans for treatment (free T4 
replacement) can be developed based on TSH test results. For a physician’s convenience, we 
simulated a lot of curves for different    values in the clinical staging chart (see Figure 5.8).  This 
may help physicians to visualize patient’s TSH curve over time. This charting method for test 
results of TSH could be used to predict the ultimate level of thyroid destruction, and thyroid 
hormone production. 
Future Work 
 Examine the relationship between the high levels of TSH in autoimmune patients and 
follicular thyroid cancer initiation.   
 Relating genetics of this disease to model results.   
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Appendix A 
Parameter used for Simulations. 
To illustrate the general results in this dissertation, we would like parameter values consistent 
with our data and the literature.  We remark in chapter 2 that the system (2.2) – (2.17) has eleven 
parameters, some of them are available from the literature, some are calculated, and some are 
determined experimentally using equilibrium value of an adult individual to match the expected 
behavior of a normal thyroid.  We will now reveal how the example parameter values are 
estimated. Suppose a normal adult has an equilibrium value of                 
              , then the unknown parameter values of this adult can be computed around the 
equilibrium value. 
Consider the equation (2.2), 
    
  
    
      
      
          
The first term accounts for the secretion rate of     and the second term accounts for the 
excretion rate of    . It has three parameters namely               .    
The parameter    is available from the medical literature (Faglia, 1987). It is greater 
than             . For this study, we will choose              and fix this number 
for all adults in the population.  The meaning of    is the largest possible secretion rate of thyroid 
stimulating hormone       from the pituitary in the absence of free thyroxine      . 
Biologically, this condition means clinical hypothyroidism (myxoedema).  
The parameter    is calculated using     chemical half-life (about 1 hour) in equation 
(2.2). The biological meaning of    is the rate at which     disappears from the blood.  
Neglecting the secretion rate in (2.2), gives  
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The solution of this rate equation is, 
                   
where        is the initial value of     in the blood.  The half-life is the time that concentration 
of a quantity takes to fall to 50% of the initial value in the blood.  Using     half-life, we obtain, 
 
 
                           
That is, 
   
     
      
             
The parameter value of    can be computed experimentally by using the equilibrium 
value of    . Thus, set 
    
  
    
and solve for    which yields    
         
        
.  Utilizing the equilibrium value and the parameter 
values, that is,                ,           ,                 and    
            . We determined the value of   , that is,             . 
Consider the equation (2.10), 
    
  
 
        
        
        
The first term accounts for the secretion rate of free    and the second one for the excretion rate 
of free   . It has three parameters namely               . 
The parameter    is calculated similar to    by using the chemical half-life of free   . 
The half-life of free    is about 7 days.  Thus,    is found to be             .  
The parameter    is calculated using both the equilibrium and limiting argument. First, 
set 
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This gives 
    
        
             
 
     
    
   
       
 
Since     quickly approaches the equilibrium value in the blood, so we will take a limit of the 
above equation, that is, 
   
     
       
     
     
    
   
       
 
     
   
                              
From this limiting equation, we can solve for   ,  
 
     
   
    
   
     
 
 
We can further use           and                 to obtain         
  
        
. 
The parameter    is computed experimentally similar to   . By setting 
    
  
                    
               
      
 
Note that: if          , then     . To avoid this situation, I picked     a little bit greater 
than 
     
 
           
  
        
 . And then use             ,          ,           
and                . This gives a value of              . 
Consider the equation (2.15), 
  
  
    
   
 
           
The first term accounts for the growth rate of the active thyroid gland and the second account for 
the destruction rate of the functional thyroid gland. The equation has again three parameters 
namely        and .  Now, setting  
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and using         ,            ,           . The value of   
   
 
 is calculated to 
be          . Note that the euthyroid state (steady state) in Chapter 3 or Chapter 4 is 
independent of the parameters           . So we could pick any value for    and   . The value 
of     and    does not change the stability of the euthyroid state. Thus, we will pick      
and     . 
Consider the equation (2.17), 
   
  
               
The first term accounts for the production rate of anti-thyroid antibodies due to the destruction of 
active thyroid gland and second term accounts for aging rate of anti-thyroid antibodies.  This 
equation has two parameters namely    and   .   
The parameter    is an important parameter in the model. We used the value of this 
parameter to describe the natural clinical course of subclinical or clinical hypothyroidism in adult 
population. We studied this parameter in detail in Chapter 4.  Thus, the reader should refer to 
Chapter 4. 
The parameter    is calculated using the half-life (about 20 days) of anti-thyroid 
antibodies in equation (2.17).  The biological meaning of    is the rate at which anti-thyroid 
antibodies disappears from the blood.  This parameter can be calculated just like    and   .  
Thus,    
      
  
           . 
Table A1 list the imaginary individual’s variable values, range, units and sources. 
Similarly Table A2 lists the parameter values for that particular imaginary individual. 
Table A1: Variable Normal Values, Ranges, Units and Sources 
Name Normal 
Value 
Normal Range Source Unit 
    1     –         Literature(Baloch etal. 2003)      
    13       Literature(Baloch etal. 2003)       
  0.015             Literature(Carle etal. 2009)   
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Table A2: Parameter Estimated Values, Ranges, Units, and Sources 
Name Estimated 
Value 
Normal 
Range 
Source Unit 
              Literature (Faglia, 1987)   
     
 
               Literature (Greenspan and 
Gardner,  2001) 
 
   
 
          Simulation 
  
        
 
                Literature(Greenspan and 
Gardner,  2001) 
 
   
 
         Simulation  
 
      
 
         Simulation   
     
 
             Literature  
   
 
              Calculation/Simulation 
  
  
 
              Simulation   
 
 
           Calculation   
  
 
 
 
 
 
 
 
 
 
 
 
   0        Dataset      
131 
 
 
 
 
Appendix B 
Solving Cubic Equation 
In this Appendix, we will outline a method to solve a cubic equation (see Selby, 1969). Suppose a 
cubic equation is given in the form              , then we will solve for   by 
substituting 
    
 
 
      
into the cubic equation and reduce to the form, 
          
where,  
    
  
 
 
and 
    
  
 
 
   
  
 
For solution let   and   
   
  
 
  
  
 
 
  
  
 
 
 
 
and 
   
  
 
  
  
 
 
  
  
 
 
 
 
then the values of   will be given by, 
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     ,  
 
 
      
   
 
      ,  
 
 
      
   
 
        
 
Now, we can of course convert from the   solutions to the   solutions using the equation (c1). 
If       are real, then: 
If 
  
 
 
  
  
  , there will be one real root and two conjugate imaginary roots 
If 
  
 
 
  
  
  , there will be three real roots of which at least two are equal 
If 
  
 
 
  
  
  , there will be three real and unequal roots 
 
Descartes’ Rule of Signs (Murray, 2002) 
Consider the polynomial in the general form, 
       
                
where the coefficients   ,            are all real and     .  Let M be the number of sign 
changes in the sequence of coefficients               , ignoring any which are zero. Descartes’ 
Rule of Signs says that there are at most M roots of     , which are real and positive, and further, 
that there are M, M-2 or M-4,… real positive roots.  By setting      and again applying the 
rule, information is obtained about the possible real negative roots.  Together these often give 
invaluable information on the sign of all roots, which from a stability point of view is usually all 
we need. 
Example: While solving for the euthyroid steady state, we encountered the cubic polynomial of 
the form, 
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Note: M=1, because the equation      has only one sign change in the sequence of coefficients 
        
  
    
     
  
  
   
    
   
    
   
 
    
    
 .  Therefore, by Descartes’ rule there is exactly one 
real positive root.   If we now set       , the equation      becomes, 
         
  
    
       
  
  
   
    
   
    
   
 
    
    
        
That is, 
        
  
    
       
  
  
   
    
   
    
   
 
    
    
        
There are two sign changes in the sequence of coefficients and so there are either two or zero real 
negative roots.  
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Appendix C 
Data Sets 
File Name File Description 
NewData.xslx 119 Hashimoto’s thyroiditis patients raw dataset 
NOPT.mat 
This file contains patient’s identification number (Id), time (Time), 
thyroid stimulating hormone (TSH), free thyroxine (FT4), and anti-
thyroid antibodies (TPOAb and TGAb). There are 119 Hashimoto’s 
thyroiditis patients in this dataset. It is created from NewData.xslx file. 
group1scaled.mat 
Always untreated patient’s dataset is created from NOPT.mat file. 
This dataset contains Id, Time, TSH, FT4, TPOAb and TGAb.  Note: 
group1 patient’s TSH and FT4 values are all scaled to normal 
reference range of TSH:              and FT4:             . 
group2scaled.mat 
Treated patients from time zero is created from NOPT.mat file.  This 
dataset contains Id, Time, TSH, FT4, TPOAb and TGAb.  Note: 
group2 patient’s TSH and FT4 values are all scaled to normal 
reference range of TSH:              and FT4:             . 
group3scaled.mat 
Untreated patients initially and then received treatment with 
Levothyroxine after developed hypothyroidism.  This dataset is 
created from NOPT.mat file.  It contains Id, Time, TSH, FT4, TPOAb 
and TGAb.  Note: group3 patient’s TSH and FT4 values are all scaled 
to normal reference range of TSH:              and FT4:    
         . 
group3scaleduntreated.mat Group3 patients’ dataset before treatment.  It is created from 
group3scaled.mat file 
patient99.mat 
Patient #99 data is extracted from group1scaled.mat file (always 
untreated patients dataset).  
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patient103.mat 
Patient #103 data is extracted from group1scaled.mat file (always 
untreated patients dataset). 
patient114.mat Patient #103 data is extracted from group3scaleduntreated.mat file. 
 
Matlab Files 
File Name File Description 
scatterplots.m This Matlab file contains codes for all scatter plots in Chapter 1. 
normal_operation.m This Matlab file contains codes for simulating the reduced 2d model in 
Chapter 3. 
norm_operation.m This Matlab file contains codes for simulating 3d model when Ab set to zero 
in Chapter 3. 
Disr_feed.m Using this Matlab file, one could generate all figures in Chapter 4. Note that 
     and    value changes for different arguments. 
bifurcation.m Using this file, one could generate all bifurcation diagrams in Chapter 4. 
euthyroid.m Using this file, one could generate euthyroidism  euthyroidism chart in 
Chapter 5. 
subclinicalhypo.m Using this file, one could generate euthyroidism  subclinical 
hypothyroidism chart and the parameterized curve (by   ) in Chapter 5. 
clinicalhypo.m Using this file, one could generate euthyroidism  subclinical  clinical 
hypothyroidism chart and the parameterized curve (by   ) in Chapter 5. 
completechart.m Using this file, one could generate the complete euthyroidism  subclinical 
  clinical hypothyroidism chart and the parameterized curve (by   ) in 
Chapter 5. 
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patient103.m Using this file, one could generate patient #103 clinical chart and the curve in 
TSH- FT4 phase plane.  
patient114.m Using this file, one could generate patient #114 clinical chart and the curve in 
TSH- FT4 phase plane. 
 
All files are available in the following Url: 
http://www.mscs.mu.edu/~stevem/bala_files.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
